<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.244" width="566.826" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="22.46" x="40.638,48.208,55.778,63.055,66.145,71.865,77.215,81.135,86.765,90.565,95.995,99.085,103.915,109.695,118.435,121.635,126.125,130.955,133.725,139.15,144.87,148.79,151.56,155.19,157.96,162.79,166.59,172.02,177.78,183.56,187.36,191.28,195.77" svgx:width="0.71,0.71,0.71,0.26,0.53,0.49,0.35,0.52,0.34,0.5,0.26,0.44,0.53,0.83,0.28,0.4,0.44,0.23,0.5,0.53,0.35,0.23,0.32,0.23,0.44,0.34,0.5,0.53,0.53,0.34,0.35,0.4,0.28" style="fill:rgb(255,255,255);font-family:Corbel2;font-size:10.0px;stroke:none;">www.nature.com/scientificreports/</text>
  </g>
  <g begin="text">
   <text y="764.23" x="544.002,549.502" svgx:width="0.45,0.51" style="fill:rgb(131,144,151);font-family:Corbel2;font-size:10.0px;stroke:none;">10</text>
  </g>
  <g begin="text">
   <text y="764.244" x="40.794,45.642,50.786,53.186,58.026,64.026,68.898,71.298,75.762,78.162" svgx:width="0.55,0.59,0.25,0.55,0.7,0.56,0.25,0.5,0.25,0.59" style="fill:rgb(131,144,151);font-family:Corbel2;font-size:8.0px;stroke:none;">SCiEntifiC</text>
   <text y="764.244" x="83.162" svgx:width="0.2" style="fill:rgb(0,0,0);font-family:Corbel2;font-size:8.0px;stroke:none;"> </text>
   <text y="764.244" x="84.762,90.218,95.194,100.434,106.738,112.194,117.186" svgx:width="0.63,0.57,0.6,0.73,0.63,0.57,0.58" style="fill:rgb(131,144,151);font-family:Corbel-Bold2;font-size:8.0px;stroke:none;">REPORTS</text>
   <text y="764.244" x="122.082,123.522,125.338,126.778,130.88" svgx:width="0.2,0.23,0.2,0.51,0.26" style="fill:rgb(0,0,0);font-family:Corbel;font-size:8.0px;stroke:none;"> | 7:</text>
   <text y="764.244" x="132.994,134.45,138.386,142.322,146.258,150.194,154.13" svgx:width="0.18,0.49,0.49,0.49,0.49,0.49,0.18" style="fill:rgb(0,0,0);font-family:MyriadPro-It;font-size:8.0px;stroke:none;"> 10295 </text>
   <text y="764.244" x="155.586,157.027,158.843,160.285,165.653,171.493,173.461,175.573,179.677,183.781,185.893,189.997,194.101,198.205,202.309,204.509,207.741,211.845,215.949,220.053,224.157,228.261,230.925,235.029,239.133,243.237,245.901,250.005,254.109,258.213,262.317,266.421,269.085" svgx:width="0.2,0.23,0.2,0.67,0.73,0.25,0.26,0.51,0.51,0.26,0.51,0.51,0.51,0.51,0.28,0.4,0.51,0.51,0.51,0.51,0.51,0.33,0.51,0.51,0.51,0.33,0.51,0.51,0.51,0.51,0.51,0.33,0.51" style="fill:rgb(0,0,0);font-family:Corbel;font-size:8.0px;stroke:none;"> | DOI:10.1038/s41598-017-10737-9</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M40.640 752.550 L554.640 752.550 "/>
  <g begin="text">
   <text y="56.5" x="155.638,160.417,165.358,168.913,171.487,176.464,180.46,184.402,187.354,189.928,194.572,199.585,203.05,205.453,210.098,212.924,215.327,220.601,225.875,230.798,235.28,239.762,241.976,246.458,248.861,255.116,259.103,262.487,266.474,268.877,276.374,280.415,284.501,287.921,292.862,296.247,300.279,305.193,307.596,310.17,315.255,317.658,321.771,324.174,328.656,330.87,335.352,336.664,340.633,348.166,350.569,354.601,359.479,363.736,367.723,370.54,373.393,377.38,379.783,386.137,388.603,391.564,396.532,398.935,403.417,407.899" svgx:width="0.52,0.53,0.37,0.27,0.54,0.42,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.51,0.3,0.23,0.57,0.57,0.53,0.48,0.48,0.23,0.48,0.23,0.69,0.43,0.37,0.43,0.23,0.82,0.43,0.44,0.37,0.53,0.37,0.43,0.53,0.23,0.27,0.55,0.23,0.44,0.23,0.48,0.23,0.48,0.23,0.42,0.82,0.23,0.42,0.53,0.46,0.43,0.31,0.31,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.48,0.48,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">purifications of EEF15.4 were measured in a 0.1 cm cuvette with 20 </text>
   <text y="56.5" x="409.195" svgx:width="0.52" style="fill:rgb(0,0,0);font-family:EuclidSymbol;font-size:9.0px;stroke:none;">μ</text>
   <text y="56.5" x="414.037,422.218,424.621,429.895,435.169,437.995,441.361,445.843,450.325,452.539,457.021,459.424,461.998,467.083,469.486,475.201,480.655,485.083,487.486,490.762,495.244,499.726,501.031,508.564,516.745,519.148,524.116,527.671,530.218,533.683,537.049,543.997,550.189,552.574,554.626" svgx:width="0.89,0.23,0.57,0.57,0.3,0.36,0.48,0.48,0.23,0.48,0.23,0.27,0.55,0.23,0.62,0.59,0.47,0.23,0.35,0.48,0.48,0.23,0.82,0.89,0.23,0.62,0.37,0.27,0.37,0.36,0.77,0.67,0.25,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">M EEf-15.4 in TBS (20 mM Tris-HCl, </text>
   <text y="66.499" x="155.629,160.039,164.449,168.859,170.065,177.526,185.635,187.777,194.317,198.358,204.477,206.787,208.929,211.071,215.877,222.861,225.003,229.413,231.555,235.965,239.169,241.311,243.453,248.022,252.997,256.912,259.054,262.499,266.457,273.744,278.484,280.851,284.766,286.908,293.188,295.579,298.466,303.362,305.504,309.462,314.437,319.279,321.421,324.308,329.165,333.08,335.222,339.8,342.687,347.544,351.459,354.888,357.03,363.309,365.702,368.588,373.445,378.023,382.783,385.618,387.76,392.17,396.58,403.474,405.616,409.979,412.28,416.426,420.323,424.238,427.548,432.162,434.473,436.615,438.757,443.435,448.005,451.434,453.576,456.463,461.32,465.235,468.715,476.147,480.231,482.598,484.74,492.162,496.039,498.296,501.131,504.524,506.666,508.808,512.153,517.037,520.995,524.953,527.83,531.259,535.3,537.442,543.623,547.538,550.847,554.672" svgx:width="0.48,0.48,0.48,0.23,0.82,0.89,0.23,0.74,0.44,0.67,0.25,0.23,0.23,0.52,0.77,0.23,0.48,0.23,0.48,0.35,0.23,0.23,0.51,0.55,0.43,0.23,0.37,0.44,0.82,0.52,0.25,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.44,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.51,0.31,0.53,0.43,0.37,0.23,0.69,0.27,0.31,0.53,0.51,0.53,0.31,0.23,0.48,0.48,0.76,0.23,0.47,0.25,0.46,0.42,0.43,0.37,0.51,0.25,0.23,0.23,0.53,0.51,0.37,0.23,0.31,0.53,0.43,0.37,0.82,0.44,0.25,0.23,0.82,0.43,0.25,0.31,0.37,0.23,0.23,0.37,0.52,0.43,0.42,0.31,0.37,0.44,0.23,0.69,0.43,0.37,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">150 mM NaCl, pH 8.4), one sample with and the other without 10% glycerol. For thermal melts, spectra were </text>
   <text y="76.498" x="155.629,159.67,163.567,168.169,173.038,175.54,178.855,182.818,187.66,189.829,192.676,195.99,200.566,208.027,210.196,214.606,219.016,223.426,225.591,228.374,233.054,235.219,239.629,244.039,248.449,249.697,254.71,262.171,264.336,269.081,272.996,275.861,282.048,286.01,289.925,294.938,297.103,301.513,303.677,306.462,311.142,313.311,317.721,322.131,323.371,326.548,332.623,334.788,341.072,343.47,346.362,351.258,353.422,357.463,359.628,363.057,367.019,374.313,379.119,381.283,384.712,388.585,391.37,395.285,397.449,402.025,404.779,406.943,411.353,412.597,415.774,421.849,424.918,432.379,434.881,439.727,444.49,447.275,451.139,453.281,455.45,460.321,464.194,467.087,471.128,473.297,477.997,480.394,483.179,487.024,491.92,494.085,498.66,501.414,503.579,507.989,509.23,512.407,518.482,520.647,524.609,529.59,534.432,536.596,541.006,542.233,547.246,554.617" svgx:width="0.44,0.42,0.51,0.53,0.27,0.37,0.43,0.53,0.23,0.3,0.37,0.51,0.82,0.23,0.48,0.48,0.48,0.23,0.31,0.51,0.23,0.48,0.48,0.48,0.23,0.55,0.82,0.23,0.51,0.43,0.31,0.69,0.43,0.43,0.55,0.23,0.48,0.23,0.31,0.51,0.23,0.48,0.48,0.23,0.34,0.67,0.23,0.69,0.27,0.31,0.53,0.23,0.44,0.23,0.37,0.44,0.82,0.52,0.23,0.37,0.44,0.31,0.43,0.23,0.51,0.3,0.23,0.48,0.23,0.34,0.67,0.33,0.82,0.27,0.55,0.53,0.31,0.43,0.23,0.23,0.53,0.44,0.31,0.44,0.23,0.52,0.27,0.31,0.42,0.53,0.23,0.51,0.3,0.23,0.48,0.23,0.34,0.67,0.23,0.44,0.55,0.53,0.23,0.48,0.23,0.55,0.82,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">acquired from 200 to 300 nm between 4 to 90 °C with a ramp rate of 1 °C/minute, data pitch of 2 °C and 1 nm </text>
   <text y="86.497" x="155.62,160.332,164.299,169.282,174.067,180.355,182.866,187.606,190.501,195.406,197.557,199.735,204.503,208.427,213.449,215.627,218.981,223.873,227.839,231.805,234.69,238.128,242.178,244.356,250.546,254.47,257.787,261.711,263.889,271.32,275.295,279.315,282.669,287.547,290.865,294.831,299.682,301.86,305.736,308.58,310.758,314.733,318.783,322.632,327.537,329.715,332.502,336.426,343.722,348.614,352.538,355.976,359.853,362.604,367.482,370.8,374.724,376.902,383.19,385.59,388.485,393.39,395.568,399.618,401.796,406.215,410.634,415.053,416.17,421.192,428.662,431.74,439.21,441.721,446.743,448.921,452.392,456.322,460.288,465.31,467.488,470.926,474.801,477.589,481.456,483.607,485.785,492.607,496.095,498.606,502.959,505.47,510.492,512.67,517.752,521.07,525.76,527.938,532.357,534.508,538.927,541.104,547.368,551.389,554.692" svgx:width="0.51,0.44,0.55,0.53,0.69,0.27,0.53,0.31,0.53,0.23,0.23,0.62,0.43,0.55,0.23,0.37,0.52,0.43,0.42,0.31,0.37,0.44,0.23,0.69,0.43,0.37,0.43,0.23,0.82,0.43,0.44,0.37,0.53,0.37,0.43,0.53,0.23,0.44,0.31,0.23,0.43,0.44,0.42,0.53,0.23,0.31,0.43,0.82,0.52,0.43,0.37,0.44,0.31,0.53,0.37,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.44,0.23,0.48,0.48,0.48,0.23,0.55,0.82,0.33,0.82,0.27,0.55,0.23,0.37,0.42,0.44,0.55,0.23,0.37,0.44,0.31,0.43,0.23,0.23,0.75,0.37,0.27,0.47,0.27,0.55,0.23,0.56,0.37,0.51,0.23,0.48,0.23,0.48,0.23,0.69,0.44,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">bandwidth. Ten spectra were measured at each temperature with a 200 nm/min scan rate. Origin Pro 8.5 was </text>
   <text y="96.496" x="155.62,160.388,163.779,167.666,172.436,174.392,177.1,181.708,183.665,188.335,190.63,195.137,197.9,199.858,203.132,207.945,211.832,215.718,218.525,221.882,225.851,227.808,231.694,236.607,240.619,242.85,246.999,250.797,254.64,256.596,263.948,267.753,269.939,272.702,274.659,279.455,283.251,286.066,290.035,291.993,295.125,301.128,307.76,309.717,317.106,319.536,324.477,326.907,334.123,338.92,346.309,348.266,352.206,355.527,357.484,360.218,365.015,369.918,373.804,376.611,379.041,383.54,388.481,390.437,394.936,397.618,399.576,402.283,406.126,413.342,418.156,421.999,425.355,429.153,431.824,436.621,439.859,443.702,446.834,448.791,453.56,456.881,459.311,464.178,468.408,470.365,473.181,477.967,481.81,483.766,489.255,493.799,495.984,498.747,502.545,509.905,513.791,518.732,523.673,525.63,528.951,531.381,535.654,543.005,547.503,549.933,554.685" svgx:width="0.53,0.37,0.43,0.53,0.23,0.31,0.51,0.23,0.52,0.25,0.51,0.31,0.23,0.37,0.52,0.43,0.42,0.31,0.37,0.44,0.23,0.44,0.55,0.44,0.25,0.46,0.42,0.43,0.23,0.82,0.43,0.25,0.31,0.23,0.53,0.44,0.31,0.44,0.23,0.35,0.67,0.74,0.23,0.82,0.27,0.55,0.27,0.82,0.53,0.82,0.23,0.44,0.37,0.23,0.3,0.53,0.55,0.42,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.31,0.43,0.82,0.52,0.43,0.37,0.44,0.31,0.53,0.37,0.43,0.35,0.23,0.53,0.37,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.59,0.51,0.25,0.31,0.42,0.82,0.44,0.55,0.55,0.23,0.37,0.27,0.47,0.82,0.51,0.27,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">used to plot spectra analyze melt data (CD minimum as function of temperature) using the Boltzmann sigmoid </text>
   <text y="106.495" x="155.62,159.49,163.999,168.805,172.584,175.374,177.786,182.268,187.191" svgx:width="0.43,0.51,0.53,0.44,0.31,0.27,0.51,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">equation.</text>
   <text y="116.494" x="167.617,172.352,177.005,179.066,186.465,190.408,194.396,197.718,202.56,205.845,209.733,211.794,216.439,220.382,225.017,227.078,231.092,235.026,237.88,240.293,244.551,246.919,249.755,253.949,256.01,259.944,264.894,269.709,271.77,275.092,279.953,283.886,287.756,290.231,295.109,298.979,301.347,304.183,307.721,309.836,311.897,317.072,321.977,325.109,329.438,335.72,337.781,344.009,347.997,351.363,353.424,358.285,362.173,365.63,368.277,372.822,376.279,383.678,387.612,392.427,394.488,400.744,403.112,405.975,410.844,412.905,417.774,420.249,424.588,429.457,432.724,437.252,439.727,444.678,449.493,451.968,456.883,461.158,463.219,467.602,471.984,475.251,481.408,485.261,487.646,489.986,492.047,496.764,499.132,502.976,505.731,509.619,512.985,515.046,518.223,524.407,529.06,532.382,535.244,539.178" svgx:width="0.62,0.51,0.23,0.82,0.43,0.44,0.37,0.53,0.37,0.43,0.23,0.53,0.44,0.51,0.23,0.44,0.42,0.31,0.27,0.46,0.27,0.31,0.46,0.23,0.44,0.55,0.53,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.46,0.23,0.23,0.57,0.54,0.34,0.47,0.69,0.23,0.69,0.44,0.37,0.23,0.52,0.43,0.37,0.3,0.51,0.37,0.82,0.43,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.47,0.53,0.36,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.48,0.48,0.36,0.69,0.43,0.25,0.25,0.23,0.52,0.25,0.44,0.31,0.43,0.37,0.23,0.35,0.67,0.51,0.37,0.31,0.44,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">To measure Fab activity and specificity, ELISA was performed with high-binding 96-well plates (Costar</text>
   <text y="113.44" x="542.66,546.269" svgx:width="0.62,0.89" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:5.85px;stroke:none;">TM</text>
   <text y="116.5" x="551.524,554.638" svgx:width="0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">) </text>
   <text y="126.499" x="155.641,161.801,165.693,168.982,172.874,174.944,178.817,183.52,187.367,190.125,194.062,198.881,200.951,207.211,209.581,212.448,217.32,219.39,222.256,227.093,230.985,233.055,238.019,242.081,246.532,250.468,255.288,257.358,261.232,265.781,270.6,273.457,276.746,281.341,283.685,285.755,289.655,293.593,297.052,300.513,302.991,306.884,310.29,312.36,317.034,320.324,324.881,327.64,331.531,334.011,339.0,341.12,343.19,348.18,351.451,357.863,363.635,369.76,376.441,378.511,382.449,387.403,392.222,394.292,399.156,403.047,407.732,410.588,413.068,417.886,421.779,423.849,428.083,432.019,435.48,437.985,441.923,446.741,449.554,452.924,454.994,458.175,462.562,466.987" svgx:width="0.69,0.43,0.37,0.43,0.23,0.42,0.51,0.44,0.31,0.43,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.55,0.44,0.5,0.43,0.53,0.23,0.42,0.51,0.55,0.31,0.37,0.51,0.25,0.23,0.42,0.44,0.37,0.37,0.27,0.43,0.37,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.23,0.55,0.36,0.74,0.63,0.67,0.74,0.23,0.44,0.55,0.53,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.46,0.44,0.37,0.27,0.44,0.55,0.31,0.37,0.23,0.35,0.48,0.48,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">were coated with the naked control carrier protein, n-DYKD and peptide variants (10 </text>
   <text y="126.499" x="468.175" svgx:width="0.52" style="fill:rgb(0,0,0);font-family:EuclidSymbol;font-size:9.0px;stroke:none;">μ</text>
   <text y="126.499" x="472.909,477.184,480.226,487.66,492.565,495.742,497.857,499.927,506.186,511.437,515.325,518.727,520.797,525.373,527.713,532.451,536.271,540.838,543.313,548.232,552.537,554.589" svgx:width="0.47,0.33,0.82,0.54,0.35,0.23,0.23,0.69,0.58,0.43,0.37,0.23,0.51,0.25,0.51,0.42,0.5,0.27,0.55,0.47,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">g/mL). After blocking, </text>
   <text y="136.498" x="155.632,160.318,165.169,168.63,171.114,176.001,179.941,184.765,186.844,191.494,195.441,200.085,203.46,205.539,211.702,215.599,218.89,222.787,224.866,228.309,232.206,235.668,238.175,242.24,244.631,246.914,251.117,253.196,258.02,260.546,262.784,267.523,270.284,274.222,279.046,281.125,285.064,290.021,294.845,296.924,301.748,305.645,308.405,312.343,316.282,319.042,322.98,327.804,329.883,336.144,338.516,341.385,346.263,348.342,352.551,357.254,361.104,363.921,367.197,371.135,375.956,378.815,381.299,384.575,389.279,394.13,401.543,405.482,410.477,412.556,417.092,420.941,425.626,430.457,434.48,437.756,444.722,450.383,455.522,457.601,460.787,465.179,467.303,471.695,476.087,480.479,484.871,486.995,489.074,493.534,498.094,502.834,505.702,510.54,514.437,517.899,522.894,524.973,530.261,532.745,537.305,540.065,544.003,547.826,552.704,554.756" svgx:width="0.52,0.53,0.37,0.27,0.54,0.43,0.53,0.23,0.53,0.44,0.51,0.37,0.23,0.69,0.43,0.37,0.43,0.23,0.37,0.43,0.37,0.27,0.44,0.25,0.25,0.46,0.23,0.53,0.27,0.25,0.53,0.31,0.43,0.53,0.23,0.44,0.55,0.53,0.23,0.53,0.43,0.31,0.43,0.42,0.31,0.43,0.53,0.23,0.69,0.27,0.31,0.53,0.23,0.47,0.51,0.44,0.31,0.36,0.44,0.55,0.31,0.27,0.36,0.53,0.53,0.82,0.44,0.55,0.23,0.5,0.44,0.52,0.52,0.44,0.36,0.77,0.62,0.56,0.23,0.35,0.48,0.23,0.48,0.48,0.48,0.48,0.23,0.23,0.47,0.51,0.53,0.31,0.53,0.43,0.37,0.55,0.23,0.59,0.27,0.51,0.31,0.43,0.42,0.53,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">purified Fabs were serially diluted and detected with goat-anti-human kappa-HRP (1:1000, Southern Biotech, </text>
   <text y="146.497" x="155.632,159.997,164.362,168.727,173.092,177.457,180.706,185.071,189.436,192.595,194.692,196.681,202.844,207.369,214.785,222.163,226.033,229.299,233.151,235.633,239.672,241.994,243.983,251.362,255.887,260.817,265.532,269.328,271.65,276.175,281.114,285.153,287.475,289.464,293.379,298.174,301.007,303.464,306.713,311.519,313.866,317.816,322.073,324.062,332.126,336.491,339.74,346.679,352.313,357.425,359.414,362.573,366.828,369.285,373.586,380.974,384.97,388.219,394.508,396.83,401.627,405.063,407.52,411.316,416.167,418.264,420.253,426.517,430.882,435.247,439.612,443.977,447.136,449.125,455.335,459.302,462.65,464.639,469.435,472.853,476.766,481.563,483.552,487.519,490.867,492.856,496.708,501.234,506.03,508.863,512.128,516.698,519.02,521.009,524.923,529.719,532.552,534.971,539.667,544.382,549.114,552.632,554.684" svgx:width="0.48,0.48,0.48,0.48,0.48,0.36,0.48,0.48,0.35,0.23,0.23,0.67,0.51,0.82,0.82,0.43,0.37,0.42,0.27,0.44,0.25,0.23,0.82,0.51,0.55,0.51,0.42,0.25,0.51,0.55,0.44,0.25,0.23,0.44,0.55,0.31,0.27,0.36,0.53,0.25,0.44,0.47,0.23,0.89,0.48,0.36,0.77,0.62,0.56,0.23,0.35,0.47,0.27,0.47,0.82,0.44,0.36,0.69,0.25,0.53,0.37,0.27,0.42,0.53,0.23,0.23,0.69,0.48,0.48,0.48,0.48,0.35,0.23,0.69,0.44,0.37,0.23,0.53,0.37,0.43,0.53,0.23,0.44,0.37,0.23,0.42,0.51,0.55,0.31,0.37,0.51,0.25,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">20060-05). Commercial monoclonal anti-Flag M2-HRP (Sigma-Aldrich, A8592) was used as control antibody. </text>
   <text y="156.496" x="155.632,161.995,165.334,169.114,173.767,178.573,183.442,187.393,192.145,194.017,199.003,202.396,204.781,208.084,215.455,217.327,221.647,223.519,229.684,233.608,236.911,238.783,243.535,246.91,250.78,255.532,257.404,259.987,264.469,267.808,269.68,272.901,276.726,281.334,284.556,288.381,291.756,295.581,300.333,303.132,306.912,309.702,312.114,316.596,321.519,323.391,327.873,330.537,332.409,336.405,338.727,341.004,342.876,347.988,352.83,355.899,360.165,366.384,368.256,373.035,376.815,379.614,383.565,385.437,389.307,394.194,398.946,400.818,404.814,407.136,409.413,411.285,416.397,421.239,424.308,428.574,434.649,437.952,439.824,445.917,449.742,452.964,456.789,458.661,461.883,465.708,470.505,474.384,478.164,480.855,484.725,489.477,491.349,495.129,497.874,499.746,502.023,505.902,509.826,513.084,515.829,517.701,520.473,526.665,529.077,532.884,536.709,538.581,544.773,547.077,549.876,554.682" svgx:width="0.71,0.37,0.44,0.52,0.53,0.56,0.44,0.53,0.23,0.56,0.37,0.27,0.37,0.82,0.23,0.48,0.23,0.69,0.44,0.37,0.23,0.53,0.37,0.43,0.53,0.23,0.3,0.51,0.37,0.23,0.37,0.43,0.52,0.37,0.43,0.37,0.43,0.55,0.31,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.44,0.25,0.25,0.23,0.57,0.54,0.34,0.47,0.69,0.23,0.53,0.44,0.31,0.44,0.23,0.44,0.55,0.53,0.23,0.44,0.25,0.25,0.23,0.57,0.54,0.34,0.47,0.69,0.37,0.23,0.69,0.43,0.37,0.43,0.23,0.37,0.43,0.52,0.43,0.44,0.31,0.43,0.53,0.23,0.44,0.31,0.23,0.25,0.43,0.44,0.37,0.31,0.23,0.31,0.69,0.27,0.42,0.43,0.23,0.69,0.27,0.31,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">GraphPad Prism 6 was used for representation of all ELISA data and all ELISAs were repeated at least twice with </text>
   <text y="166.495" x="155.632,159.007,162.832,167.593,171.463,174.802,178.581,181.272,185.097,186.933,189.21,191.622,195.834,199.704,204.591,209.289,211.341,213.177,217.758,221.637,226.209,228.045,231.915,236.802,241.554,243.39,248.043,252.822,256.729,260.868,264.693,266.529,271.137,274.359,278.184,282.945,286.815,290.154,293.934,296.724,299.136,303.617,308.468,311.771" svgx:width="0.37,0.43,0.52,0.44,0.37,0.44,0.31,0.43,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.23,0.23,0.53,0.44,0.51,0.23,0.44,0.55,0.53,0.23,0.52,0.53,0.44,0.47,0.43,0.23,0.52,0.37,0.43,0.52,0.44,0.37,0.44,0.31,0.27,0.51,0.55,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">separate ligand, Fab and phage preparations.</text>
   <text y="188.5" x="155.638,162.658,167.938,171.858,177.138,179.448,184.728,189.768,195.048,197.663,200.313,205.593,211.293,213.908,216.558,219.173,223.093,227.871,230.921" svgx:width="0.69,0.51,0.38,0.51,0.21,0.51,0.49,0.51,0.25,0.25,0.51,0.56,0.25,0.25,0.25,0.38,0.51,0.29,0.21" style="fill:rgb(0,0,0);font-family:Corbel-Bold2;font-size:10.0px;stroke:none;">Data availability. </text>
   <text y="188.5" x="241.045,250.775,254.726,257.012,261.919,265.828,268.755,272.832,275.118,278.044,282.952,286.86,289.731,292.017,295.403,300.203,304.947,309.872,314.482,318.04,320.911,323.197,326.124,331.022,334.973,337.259,342.2,347.216,352.094,354.632,359.612,363.95,367.379,369.665,374.274,377.064,379.35,382.277,387.209,389.722,393.151,395.437,398.823,401.606,406.511,411.327,415.584,417.87,421.869,425.219,429.17,431.456,435.373,439.666,443.663,446.248,448.68,452.688,457.325,459.728,463.679,465.965,468.847,472.197,476.807,484.304,486.59,489.517,494.415,498.366,500.652,504.585,509.195,512.716,516.067,520.018,523.404,528.329,532.939,537.955,542.833,545.371,550.35,554.562" svgx:width="1.07,0.43,0.23,0.53,0.44,0.31,0.44,0.23,0.31,0.53,0.44,0.31,0.23,0.37,0.53,0.52,0.52,0.51,0.37,0.31,0.23,0.31,0.53,0.43,0.23,0.54,0.55,0.53,0.27,0.55,0.47,0.37,0.23,0.51,0.3,0.23,0.31,0.53,0.27,0.37,0.23,0.37,0.31,0.53,0.53,0.46,0.23,0.44,0.37,0.43,0.23,0.44,0.46,0.44,0.27,0.25,0.44,0.51,0.25,0.43,0.23,0.3,0.37,0.51,0.82,0.23,0.31,0.53,0.43,0.23,0.42,0.51,0.37,0.37,0.43,0.37,0.52,0.51,0.55,0.53,0.27,0.55,0.47,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">The data that support the findings of this study are available from the corresponding </text>
   <text y="198.499" x="155.635,159.42,164.096,166.901,171.677,176.165,179.513,181.457,186.134,190.935,195.424,200.356,202.3,205.528,209.412,213.342,216.722,221.21,226.111,229.996,234.511,236.797,240.631,242.575,245.802,249.677,254.192,258.98,262.814,266.077,268.831,270.892,272.836,279.61,284.232,286.986,292.98,299.519,305.117,307.061,310.877,315.366,322.571,327.194,331.87,334.566,338.4,341.748,343.692,347.508,352.185,356.946,360.78,364.092,366.036,369.911,373.139,376.973,378.917,381.676,384.903,388.779,392.573,394.793,398.933,400.877,404.672,408.848,412.723,415.186,417.495,421.38,425.894,428.18,432.014,433.958,440.155,442.465,445.269,450.084,452.028,455.256,459.09,463.352,465.743,469.007,471.802,475.15,478.936,481.731,484.152,488.639,493.571,495.515,500.003,504.935,508.143,510.429,512.85,517.743,521.577,523.521,527.307,530.061" svgx:width="0.44,0.53,0.31,0.53,0.51,0.37,0.23,0.53,0.52,0.51,0.55,0.23,0.37,0.43,0.44,0.37,0.51,0.55,0.44,0.51,0.25,0.43,0.23,0.37,0.43,0.51,0.53,0.43,0.37,0.31,0.23,0.23,0.75,0.52,0.31,0.67,0.74,0.62,0.23,0.42,0.51,0.82,0.52,0.53,0.31,0.43,0.37,0.23,0.42,0.51,0.53,0.43,0.37,0.23,0.44,0.37,0.43,0.23,0.3,0.37,0.43,0.43,0.25,0.46,0.23,0.44,0.46,0.44,0.27,0.25,0.44,0.51,0.25,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.37,0.43,0.47,0.27,0.37,0.31,0.37,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.55,0.36,0.25,0.27,0.55,0.43,0.23,0.44,0.31,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">author upon reasonable request. OptCDR computer codes are freely available with registration on-line at </text>
   <text y="198.499" x="532.005,536.645,539.307,541.967,546.692,548.753,551.741" svgx:width="0.53,0.31,0.31,0.52,0.23,0.33,0.33" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">http://</text>
   <text y="208.498" x="155.635,161.908,168.181,173.689,175.741,183.085,186.955,190.294,194.164,199.06,202.984,206.287,210.544,213.765,218.257,222.928,227.383,229.435,233.242,237.723,245.094,248.073,251.331,256.074,260.538,267.909,270.294,273.552,276.855,279.267,283.749,288.672,291.651,298.419,303.036,305.781,311.766,318.299,323.888,328.388,332.708,334.76,339.395,342.185" svgx:width="0.69,0.69,0.69,0.23,0.82,0.44,0.37,0.44,0.55,0.44,0.37,0.47,0.37,0.51,0.53,0.52,0.23,0.42,0.51,0.82,0.33,0.37,0.53,0.51,0.82,0.27,0.37,0.37,0.27,0.51,0.55,0.33,0.75,0.52,0.31,0.67,0.74,0.62,0.5,0.48,0.23,0.53,0.31,0.82" style="fill:rgb(0,0,255);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">www.maranasgroup.com/submission/OptCDR_2.htm</text>
   <text y="208.498" x="349.556" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:9.0px;stroke:none;">.</text>
   <text y="230.5" x="155.638,162.33,167.973,171.581,177.224,181.074,186.717,192.822,197.673,203.316" svgx:width="0.63,0.51,0.33,0.51,0.35,0.51,0.56,0.44,0.51,0.42" style="fill:rgb(0,0,0);font-family:Corbel-Bold2;font-size:11.0px;stroke:none;">References</text>
   <text y="239.0" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,171.936,175.063,178.738,181.925,184.235,185.945,187.475,192.688,194.398,195.928,202.61,204.32,206.031,207.561,209.87,213.605,217.678,220.865,223.618,225.328,226.858,230.413,232.123,233.653,238.865,240.576,242.105,247.438,248.968,253.071,256.317,259.812,261.822,265.895,269.037,270.747,272.277,278.022,279.732,281.262,285.297,287.007,288.537,296.54,299.727,301.257,303.59,307.565,310.752,313.535,316.685,320.682,323.869,327.762,330.087,332.097,335.269,336.799,342.912,346.647,350.719,354.611,357.738,359.636,363.371,367.451,370.781,372.678,374.208,377.433,381.393,383.718,385.698,389.576,393.468,397.375,400.818,402.348,408.468,411.693,414.445,418.12,421.308,423.595,425.305" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.57,0.42,0.5,0.43,0.37,0.23,0.23,0.74,0.23,0.23,0.89,0.23,0.23,0.23,0.33,0.51,0.55,0.43,0.37,0.23,0.23,0.47,0.23,0.23,0.74,0.23,0.23,0.71,0.23,0.54,0.43,0.46,0.27,0.55,0.43,0.23,0.23,0.77,0.23,0.23,0.54,0.23,0.23,1.07,0.43,0.23,0.31,0.53,0.43,0.37,0.44,0.52,0.43,0.53,0.31,0.27,0.42,0.23,0.82,0.51,0.55,0.51,0.42,0.25,0.51,0.55,0.44,0.25,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.82,0.44,0.37,0.5,0.43,0.31,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 1. Ecker, D. M., Jones, S. D. &amp; Levine, H. L. The therapeutic monoclonal antibody market. </text>
   <text y="239.0" x="426.835,433.405,438.048,441.647" svgx:width="0.88,0.66,0.49,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">MAbs</text>
   <text y="239.0" x="444.208" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="239.0" x="445.738" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">7</text>
   <text y="239.0" x="449.488,451.198,452.728,456.328,460.228,463.828,467.428,468.958,471.553,475.153,478.753,482.353,485.953,488.548" svgx:width="0.23,0.23,0.48,0.52,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 9–14 (2015).</text>
   <text y="247.497" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,172.168,175.393,179.533,183.508,186.733,189.875,191.585,193.115,196.295,198.005" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.7,0.44,0.55,0.53,0.43,0.43,0.23,0.23,0.56,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 2. Vanhee, P. </text>
   <text y="247.497" x="199.535,202.482,204.785,206.33,209.922" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="247.497" x="211.798,213.508,215.038,220.138,223.873,229.872,233.72,237.613,239.945,243.095,245.42,247.43,251.165,255.245,258.575,260.472,262.002,265.962,269.15,271.902,273.912,277.46,281.562,283.092,286.827,289.047,290.577,294.575,297.762,301.609,303.934,305.944,309.904,313.092,314.622,316.519,318.529,322.039,325.263,329.336,333.274,336.027,337.737" svgx:width="0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Computational design of peptide ligands. </text>
   <text y="247.497" x="339.267,343.227,345.829,348.829,352.767,356.607,359.134,360.679,364.902,366.918,370.353,372.581,375.536,378.311,382.016,385.953,389.403" svgx:width="0.6,0.37,0.4,0.53,0.51,0.34,0.23,0.58,0.27,0.47,0.31,0.4,0.38,0.51,0.53,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Trends Biotechnol</text>
   <text y="247.497" x="391.281" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="247.497" x="392.811,396.561" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">29</text>
   <text y="247.497" x="400.311,402.021,403.551,407.151,410.751,414.351,418.251,421.851,425.451,429.051,430.581,433.176,436.776,440.376,443.976,447.576,450.171" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 231–239 (2011).</text>
   <text y="255.995" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,171.432,173.364,176.498,178.408,180.237,181.924,183.349,188.314,190.002,191.427,196.615,198.303,199.99,201.415,207.016,208.979,211.67,214.4,216.087,217.512,219.641,221.328,222.753,227.913,229.601,231.288,232.713,238.254,241.455,245.503,248.653,252.522,255.625,259.345,261.033,262.458,267.24,268.928,270.353,274.59,276.278,277.703,283.013,284.438,288.074,291.176,295.159,299.207,302.372,304.36,308.297,311.462,313.748,315.436,316.861,322.201,323.888,325.313,330.846,334.011,336.741,338.729,342.252,346.332,348.32,352.337,355.825,357.25,360.451,364.386,366.687,368.675,374.795,376.782,379.932,382.593,386.357,390.052,392.06,395.366,397.241,398.666,402.638,405.803,409.627,411.927,413.915,417.852,421.017,423.747,425.435,426.86,428.988,432.699,435.502,441.622,443.047,445.175,448.923,450.834,452.709,456.39,461.505,464.235,465.66,467.901,471.861,475.91,479.11,481.411,483.398,487.109,491.189,492.876" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.53,0.26,0.43,0.25,0.25,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,0.23,0.77,0.27,0.37,0.37,0.23,0.23,0.33,0.23,0.23,0.69,0.23,0.23,0.23,0.77,0.44,0.55,0.42,0.51,0.42,0.5,0.23,0.23,0.63,0.23,0.23,0.57,0.23,0.23,0.71,0.23,0.47,0.42,0.53,0.55,0.43,0.27,0.53,0.43,0.37,0.23,0.23,0.71,0.23,0.23,0.74,0.43,0.37,0.27,0.47,0.55,0.27,0.55,0.47,0.23,0.44,0.55,0.31,0.27,0.82,0.27,0.42,0.37,0.51,0.51,0.27,0.44,0.25,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.37,0.23,0.23,0.3,0.51,0.37,0.82,0.23,0.3,0.51,0.25,0.25,0.51,0.69,0.37,0.23,0.3,0.53,0.55,0.42,0.31,0.27,0.51,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 3. Fjell, C. D., Hiss, J. A., Hancock, R. E. &amp; Schneider, G. Designing antimicrobial peptides: form follows function. </text>
   <text y="255.995" x="494.301,499.346,502.832,505.109,506.542,511.002,514.01,517.338,518.771,524.088,526.877,530.774,533.9,535.332,540.65,542.705,545.23,548.017,551.421" svgx:width="0.7,0.49,0.31,0.23,0.6,0.4,0.45,0.23,0.71,0.37,0.53,0.42,0.23,0.71,0.27,0.34,0.38,0.47,0.45" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nat Rev Drug Discov</text>
   <text y="255.995" x="554.638" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="264.492" x="167.638,171.388" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">11</text>
   <text y="264.492" x="175.138,176.848,178.378,181.978,185.578,189.478,193.078,196.678,198.208,200.803,204.403,208.003,211.603,215.203,217.798" svgx:width="0.23,0.23,0.48,0.48,0.52,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 37–51 (2012).</text>
   <text y="272.99" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,172.903,176.135,179.955,181.96,184.288,187.558,189.608,191.4,193.23,199.995,201.788,203.618,207.735,209.528" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.69,0.42,0.51,0.27,0.31,0.43,0.27,0.23,0.23,0.89,0.23,0.23,0.54,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 4. Azoitei, M. L. </text>
   <text y="272.99" x="211.358,214.391,216.779,218.624,222.302" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="272.99" x="224.278,226.07,227.9,233.085,236.906,242.991,246.923,250.901,253.318,256.553,258.963,261.056,264.876,269.041,272.456,274.436,276.266,280.308,283.578,286.413,288.506,292.138,296.323,298.153,301.973,304.275,306.105,310.031,312.801,316.628,318.956,322.226,324.318,328.503,330.333,333.643,337.688,340.098,342.191,345.725,348.995,353.123,355.958,357.788,360.205,364.273,367.508,369.878,371.708,373.8,377.845,380.172,383.442,386.307,389.682,392.992,395.362,397.192,402.437,404.441,406.859,410.947,412.777,415.194,419.254,422.524,424.354,429.424,434.954,439.739,441.569,447.396,451.079,452.909,454.889,458.866,462.694,466.706,468.536,472.356,474.659,476.489,482.316,484.956,490.311,492.141,495.947,498.716,502.664,506.039,510.122,512.051,515.576,517.406,521.564,524.834,528.811,531.221,534.086,537.501,539.481,541.574,544.806,546.899,551.027,554.537" svgx:width="0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.37,0.23,0.31,0.53,0.44,0.31,0.23,0.27,0.55,0.31,0.43,0.37,0.44,0.42,0.31,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.43,0.23,0.67,0.74,0.63,0.23,0.77,0.48,0.23,0.25,0.51,0.51,0.52,0.23,0.51,0.3,0.23,0.77,0.34,0.7,0.23,0.51,0.37,0.51,0.44,0.53,0.25,0.46,0.23,0.55,0.43,0.53,0.31,0.37,0.44,0.25,0.27,0.42,0.27,0.55,0.47,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing </text>
   <text y="281.487" x="167.638,170.863,174.823,177.148,179.128,183.005,186.897,190.806,194.248,195.778,199.378,203.346,206.946,208.656" svgx:width="0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.48,0.53,0.48,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">antibody 2F5. </text>
   <text y="281.487" x="210.186,214.318,216.921,220.356,222.583,225.583,227.533,231.523" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Proteins</text>
   <text y="281.487" x="234.051" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="281.487" x="235.588,239.338" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">82</text>
   <text y="281.487" x="243.088,244.798,246.328,249.928,253.528,257.128,260.728,264.628,268.228,271.828,275.428,279.028,280.558,283.153,286.753,290.353,293.953,297.553,300.148" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 2770–2782 (2014).</text>
   <text y="289.985" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,171.583,173.458,176.623,178.589,181.29,185.273,191.371,194.574,198.654,200.342,201.767,205.299,206.987,208.412,210.543,212.23" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.53,0.25,0.43,0.27,0.37,0.53,0.82,0.44,0.55,0.23,0.23,0.47,0.23,0.23,0.33,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 5. Fleishman, S. J. </text>
   <text y="289.985" x="213.655,216.581,218.862,220.302,223.872" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="289.985" x="225.726,227.413,228.838,233.916,237.63,243.608,247.434,251.305,253.616,256.744,259.047,261.035,264.748,268.806,272.114,273.989,275.414,279.352,282.517,285.247,287.234,290.76,294.84,296.265,299.978,302.176,303.601,307.419,310.082,313.804,316.025,319.19,321.177,325.198,327.928,329.353,331.664,334.867,337.568,340.997,344.162,346.465,348.452,352.473,355.961,357.385,359.696,363.65,366.815,368.24,371.39,375.103,379.123,381.914,385.079,388.058,391.448,394.652,398.589,400.014,402.707,404.929,408.094,414.214,415.639,418.302,421.467,424.994,426.981,430.694,434.774,436.199,439.912,442.11,443.535,445.522,449.602,453.488,457.448,460.613,464.693,467.821,471.091,472.516,476.469,479.634,485.732,488.966,492.499,496.04,497.826,501.697,504.0,505.987,510.067,512.055,516.135,517.822" svgx:width="0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.31,0.44,0.37,0.47,0.43,0.31,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.42,0.51,0.55,0.37,0.43,0.37,0.46,0.43,0.53,0.23,0.37,0.31,0.43,0.82,0.23,0.37,0.43,0.47,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.27,0.55,0.53,0.53,0.43,0.55,0.42,0.44,0.23,0.53,0.43,0.82,0.44,0.47,0.47,0.25,0.53,0.31,0.27,0.55,0.27,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. </text>
   <text y="289.985" x="519.247,522.781,525.624,527.619,530.597,534.512,537.302" svgx:width="0.47,0.38,0.27,0.4,0.53,0.38,0.4" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Science</text>
   <text y="289.985" x="540.313" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="289.985" x="541.738,545.465,549.193" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">332</text>
   <text y="289.985" x="552.92,554.63" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, </text>
   <text y="298.482" x="167.638,171.238,174.838,178.438,182.338,185.938,189.538,193.138,194.668,197.263,200.863,204.463,208.063,211.663,214.258" svgx:width="0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">816–821 (2011).</text>
   <text y="306.98" x="155.638,157.363,159.328,162.928,164.638,166.363,167.638,172.133,177.304,181.132,185.267,188.893,190.693,192.553,195.826,197.626,199.486,204.791,206.591,208.391,210.251,216.899,220.262,223.168,226.43,230.296,232.309,235.691,237.491,239.351,241.597,243.397,245.257,250.157,251.957,253.817,259.24,261.1,266.57,269.896,273.866,277.116,279.062,280.862,282.722,288.174,289.974,291.834,294.08,295.88,297.74,302.183,304.961,308.916,312.299,316.389,318.327,321.86,323.72,327.885,331.163,335.148,337.566,340.439,343.861,345.848,347.948,351.188,353.288,357.425,361.025,362.885,366.203,370.256,372.674,374.747,378.717,382.703,386.753,388.853,392.13,394.973,396.833,400.151,404.316,408.366,410.226,412.651,416.719,419.996,421.856,424.762,428.087,431.405,434.183,437.404,441.499,443.359,445.604,449.432,452.305,454.165,457.483,461.675,463.535,469.37,472.018,476.911,479.671,483.361,485.221,488.783,492.166,495.428,498.691,500.791,504.956,508.234,510.034,511.894,514.319,518.387,521.665,523.525,526.802,530.968,535.018,536.878,540.706,543.016,544.876,547.301,551.369,554.557" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.67,0.69,0.51,0.55,0.47,0.23,0.23,0.56,0.23,0.23,0.74,0.23,0.23,0.23,0.89,0.44,0.37,0.42,0.51,0.25,0.44,0.23,0.23,0.33,0.23,0.23,0.63,0.23,0.23,0.71,0.23,0.74,0.44,0.51,0.43,0.25,0.23,0.23,0.71,0.23,0.23,0.33,0.23,0.23,0.59,0.37,0.51,0.44,0.53,0.25,0.46,0.23,0.55,0.43,0.53,0.31,0.37,0.44,0.25,0.27,0.42,0.27,0.55,0.47,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.44,0.55,0.53,0.23,0.31,0.53,0.43,0.23,0.37,0.43,0.44,0.37,0.42,0.53,0.23,0.3,0.51,0.37,0.23,0.44,0.55,0.23,0.77,0.34,0.7,0.36,0.48,0.23,0.46,0.44,0.42,0.42,0.27,0.55,0.43,0.23,0.23,0.31,0.53,0.43,0.23,0.43,0.55,0.53,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 6. Kwong, P. D., Mascola, J. R. &amp; Nabel, G. J. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the </text>
   <text y="315.477" x="167.638,171.515,174.703,178.25,180.26,184.362,188.465,190.475,194.517,198.05,199.76" svgx:width="0.51,0.43,0.47,0.27,0.55,0.55,0.27,0.55,0.47,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">beginning. </text>
   <text y="315.477" x="201.29,206.36,209.87,212.173,213.718,218.203,221.233,224.585,226.13,228.35,234.125,239.9,243.8,247.738,251.188" svgx:width="0.7,0.49,0.31,0.23,0.6,0.4,0.45,0.23,0.34,0.79,0.79,0.53,0.53,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nat Rev Immunol</text>
   <text y="315.477" x="253.055" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="315.477" x="254.585,258.335" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">13</text>
   <text y="315.477" x="262.085,263.795,265.325,268.925,272.525,276.125,280.025,283.625,287.225,290.825,292.355,294.95,298.55,302.15,305.75,309.35,311.945" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 693–701 (2013).</text>
   <text y="323.975" x="155.63,157.355,159.32,162.92,164.63,166.355,167.63,172.655,176.63,180.373,182.705,186.71,188.743,192.035,193.745,195.275,200.263,201.973,203.503,208.835,210.365,214.468,217.656,220.377,224.12,225.83,227.36,232.542,234.252,235.782,242.465,244.175,245.705,250.76,253.984,258.057,261.792,265.894,267.904,271.099,274.429,276.327,277.857,280.572,282.896,285.753,289.736,292.961,295.173,299.156,301.841,305.028,307.781,309.311,311.463,315.198,317.981,319.511,321.843,325.818,329.006,330.536,334.368,337.811,341.808,344.996,347.995,351.468,354.693,357.52,359.553,362.785,366.543,368.44,371.628,373.158,375.843,379.03,382.577,384.587,388.322,392.364,395.117,396.647,400.382,402.602,404.132,406.142,412.284,418.284,422.267,426.339,430.164,433.727,435.624,439.412,443.139,447.159,449.057,451.067,455.109,457.862,459.572" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.67,0.53,0.51,0.31,0.53,0.27,0.44,0.23,0.23,0.67,0.23,0.23,0.71,0.23,0.54,0.43,0.37,0.5,0.23,0.23,0.69,0.23,0.23,0.89,0.23,0.23,0.67,0.44,0.55,0.51,0.55,0.27,0.42,0.44,0.25,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.37,0.23,0.3,0.51,0.37,0.23,0.31,0.53,0.43,0.23,0.53,0.46,0.52,0.43,0.37,0.46,0.44,0.37,0.27,0.44,0.51,0.25,0.43,0.23,0.37,0.43,0.47,0.27,0.51,0.55,0.37,0.23,0.51,0.3,0.23,0.27,0.82,0.82,0.53,0.55,0.51,0.47,0.25,0.51,0.51,0.53,0.25,0.27,0.55,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 7. Chothia, C. &amp; Lesk, A. M. Canonical structures for the hypervariable regions of immunoglobulins. </text>
   <text y="323.975" x="461.102,463.509,465.055,471.4,474.85,476.716,478.261,482.484,484.501,487.951" svgx:width="0.32,0.23,0.88,0.47,0.25,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">J Mol Biol</text>
   <text y="323.975" x="489.853" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="323.975" x="491.383,495.133,498.883" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">196</text>
   <text y="323.975" x="502.633,504.343,505.873,509.473,513.073,516.673,520.573,524.173,527.773,531.373,532.903,535.498,539.098,542.698,546.298,549.898,552.493" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 901–917 (1987).</text>
   <text y="332.472" x="155.63,157.355,159.32,162.92,164.63,166.355,167.63,174.796,178.771,180.664,182.879,186.01,187.877,191.035,194.563,198.068,199.748,201.166,206.708,208.388,209.806,214.586,216.266,217.684,222.986,224.404,229.102,232.3,235.457,238.18,239.86,241.277,246.43,248.11,249.527,254.308,255.988,257.405,263.738,268.891,275.543,277.223,278.641,281.839,285.911,287.329,289.309,295.282,299.095,301.753,305.431,308.816,312.014,315.944,317.362,320.665,322.532,325.955,329.663,332.464,334.357,336.662,340.637,346.75,348.167,350.293,354.001,356.753,358.171,364.256,368.121,372.051,375.181,377.089,378.956,380.936,384.952,388.432,389.849,393.047,396.98,399.279,401.232,405.082,408.948,412.878,414.858,418.015,420.738,422.155,425.863,429.936,431.353,433.658,437.607,440.764,442.182,449.434,453.664,457.92,459.6" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.97,0.53,0.27,0.31,0.43,0.25,0.43,0.47,0.47,0.23,0.23,0.74,0.23,0.23,0.63,0.23,0.23,0.71,0.23,0.63,0.43,0.43,0.37,0.23,0.23,0.69,0.23,0.23,0.63,0.23,0.23,0.97,0.69,0.89,0.23,0.23,0.44,0.55,0.23,0.27,0.82,0.52,0.37,0.51,0.46,0.43,0.53,0.23,0.44,0.25,0.47,0.51,0.37,0.27,0.31,0.53,0.82,0.23,0.3,0.51,0.37,0.23,0.82,0.51,0.53,0.43,0.25,0.25,0.27,0.55,0.47,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.51,0.55,0.23,0.31,0.53,0.43,0.23,0.97,0.57,0.59,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 8. Whitelegg, N. R. &amp; Rees, A. R. WAM: an improved algorithm for modelling antibodies on the WEB. </text>
   <text y="332.472" x="461.017,465.123,467.698,471.106,473.306,476.279,478.199,482.162,483.594,487.64,491.502" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.23,0.56,0.53,0.42" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Protein Eng</text>
   <text y="332.472" x="494.788" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="332.472" x="496.205,499.933" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">13</text>
   <text y="332.472" x="503.653,505.333,506.75,510.32,513.891,517.461,521.331,524.901,528.471,532.041,533.458,536.023,539.593,543.163,546.733,550.303,552.868" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 819–824 (2000).</text>
   <text y="340.97" x="155.623,157.34799999999998,159.313,162.913,164.623,166.34799999999998,167.623,174.253,176.3,180.11,182.008,185.833,188.585,190.295,191.825,197.008,198.718,200.248,204.508,206.218" svgx:width="0.23,0.55,0.48,0.23,0.23,0.55,0.89,0.27,0.5,0.25,0.51,0.37,0.23,0.23,0.69,0.23,0.23,0.57,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 9. Miklos, A. E. </text>
   <text y="340.97" x="207.748,210.695,212.998,214.543,218.135" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="340.97" x="220.01,221.72,223.25,226.7,229.025,231.882,235.865,239.09,241.302,245.285,247.97,251.157,253.827,257.675,260.945,263.757,266.982,270.942,272.472,276.432,279.619,282.372,284.382,287.928,292.031,293.561,297.296,299.516,301.046,303.761,307.653,311.651,314.838,317.523,320.65,324.633,327.858,330.581,334.031,337.255,341.17,342.88,344.41,348.415,350.425,353.988,358.03,359.875,363.318,364.848,367.18,371.155,374.343,377.17,383.283,387.018,389.703,392.89,395.643,397.63,400.344,402.677,405.902,409.862,412.149,413.679,416.904,420.865,423.19,425.17,429.047,432.94,436.9,438.91,442.097,444.85,446.56" svgx:width="0.23,0.23,0.47,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.36,0.51,0.44,0.37,0.43,0.53,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.37,0.53,0.52,0.43,0.37,0.42,0.53,0.44,0.37,0.47,0.43,0.53,0.23,0.23,0.53,0.27,0.47,0.53,0.25,0.46,0.23,0.31,0.53,0.43,0.37,0.82,0.51,0.37,0.43,0.37,0.27,0.37,0.31,0.44,0.55,0.31,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Structure-based design of supercharged, highly thermoresistant antibodies. </text>
   <text y="340.97" x="448.09,452.852,456.632,459.632,465.535,467.08,471.302,473.32,476.77" svgx:width="0.63,0.51,0.4,0.79,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Chem Biol</text>
   <text y="340.97" x="478.637" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="340.97" x="480.185,483.935" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">19</text>
   <text y="340.97" x="487.685,489.395,490.925,494.525,498.125,501.725,505.625,509.225,512.826,516.425,517.956,520.55,524.15,527.75,531.35,534.95,537.545" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 449–455 (2012).</text>
   <text y="349.467" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,172.273,176.255,178.94,182.833,186.815,190.107,191.817,193.347,198.56,200.27,201.98,203.51,207.02,211.025,213.035,215.817,219.042,221.007,222.717,224.247,229.992,231.702,233.412,234.942,237.2,240.492,243.665,247.452,251.262,254.075,257.81,261.912,263.622,265.152,271.835,273.545,275.075,278.255,279.965,281.495,286.827,288.357,293.735,297.065,300.807,304.032,310.032,314.015,316.797,320.09,321.8,323.33,329.075,330.785,332.315,337.415,341.15,347.15,350.997,354.89,357.132,360.32,362.922,365.592,368.817,370.827,374.787,378.012,381.972,383.502,386.727,390.687,393.012,394.992,398.87,402.762,406.67,410.112,411.642,415.602,418.79,421.542,423.552,427.1,431.202,432.912" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.67,0.53,0.37,0.51,0.53,0.44,0.23,0.23,0.74,0.23,0.23,0.23,0.47,0.53,0.27,0.37,0.44,0.27,0.23,0.23,0.77,0.23,0.23,0.23,0.33,0.44,0.42,0.51,0.51,0.37,0.51,0.55,0.23,0.23,0.89,0.23,0.23,0.56,0.23,0.23,0.71,0.23,0.74,0.44,0.5,0.44,0.82,0.53,0.37,0.44,0.23,0.23,0.77,0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.43,0.37,0.36,0.44,0.27,0.53,0.43,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 10. Kuroda, D., Shirai, H., Jacobson, M. P. &amp; Nakamura, H. Computer-aided antibody design. </text>
   <text y="349.467" x="434.442,438.574,441.177,444.612,446.839,449.839,451.789,455.779,457.324,461.397,465.289,468.439,469.984,475.346,478.286,480.814,482.359,485.913,488.793" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.23,0.56,0.53,0.42,0.23,0.71,0.4,0.34,0.23,0.47,0.4,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Protein Eng Des Sel</text>
   <text y="349.467" x="490.661" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="349.467" x="492.223,495.973" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">25</text>
   <text y="349.467" x="499.723,501.433,502.963,506.563,510.163,513.763,517.663,521.263,524.863,528.463,529.993,532.588,536.188,539.788,543.388,546.988,549.583" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 507–521 (2012).</text>
   <text y="357.965" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,174.165,177.377,180.364,183.846,185.841,189.929,191.624,193.056,195.196,196.891,198.323,201.863,203.558,204.991,210.308,211.741,215.831,219.523,224.67,230.777,233.989,238.076,239.771,241.204,246.934,248.629,250.061,254.331,256.026,257.459,262.171,265.382,269.327,272.5,275.237,277.232,280.767,284.855,286.85,290.879,294.374,295.807,299.019,303.107,304.539,307.751,311.699,314.011,315.977,319.842,323.722,327.616,331.043,332.476,334.757,337.525,340.767,344.302,350.401,353.573,357.521,359.793,361.226,363.365,367.087,369.854,371.287,373.492,376.749,379.451,381.681,384.854,387.621,389.053,392.311,395.013,397.813,401.692,404.849,406.869,410.006,412.318,414.313,418.035,422.122,423.555,428.702,430.609,432.928,436.918,438.351,440.258,442.531,445.268,446.701,449.913,453.859,456.172,458.167,461.603,464.776,468.863,470.558" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.89,0.44,0.37,0.46,0.27,0.55,0.23,0.23,0.33,0.23,0.23,0.47,0.23,0.23,0.71,0.23,0.54,0.51,0.69,0.82,0.44,0.55,0.23,0.23,0.77,0.23,0.23,0.59,0.23,0.23,0.63,0.43,0.53,0.43,0.37,0.27,0.47,0.55,0.27,0.55,0.47,0.23,0.44,0.55,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.3,0.37,0.44,0.47,0.82,0.43,0.55,0.31,0.23,0.3,0.51,0.37,0.23,0.3,0.44,0.37,0.31,0.43,0.37,0.23,0.44,0.37,0.37,0.51,0.42,0.27,0.44,0.31,0.27,0.51,0.55,0.23,0.69,0.27,0.31,0.53,0.23,0.27,0.31,0.37,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 11. Marvin, J. S. &amp; Lowman, H. B. Redesigning an antibody fragment for faster association with its antigen. </text>
   <text y="357.965" x="471.991,476.2,478.203,481.683,484.445,488.212,491.199,496.96,499.025,501.465,503.686,506.569" svgx:width="0.58,0.27,0.47,0.38,0.51,0.4,0.79,0.27,0.34,0.31,0.37,0.44" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Biochemistry</text>
   <text y="357.965" x="509.983" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="357.965" x="511.415,515.15" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">42</text>
   <text y="357.965" x="518.885,520.58,522.013,525.598,529.183,532.768,536.353,540.238,543.823,547.408,550.993,554.592" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 7077–7083 </text>
   <text y="366.462" x="167.623,170.218,173.818,177.418,181.018,184.618,187.213" svgx:width="0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">(2003).</text>
   <text y="374.96" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,172.648,176.623,179.81,183.913,187.993,191.218,197.3,200.113,203.3,205.512,207.822,210.717,212.427,214.01,219.582,221.292,223.002,224.585,229.13,232.835,236.3,240.372,244.077,247.002,248.712,250.295,254.487,256.197,257.907,259.49,264.395,267.552,270.995,273.807,276.995,279.305,281.015,282.597,286.79,288.5,290.21,291.792,297.35,300.507,302.442,306.185,307.895,309.477,313.76,315.47,317.053,322.385,323.968,327.973,330.658,334.4,338.293,340.58,342.29,343.873,348.155,349.865,351.448,355.483,357.193,358.775,364.333,367.52,370.273,372.283,375.83,379.932,381.515,385.25,387.47,389.053,391.385,395.36,398.548,401.33,404.48,408.478,411.665,415.558,417.883,419.893,423.065,424.648,428.488,431.173,434.915,437.158,440.345,442.355,446.398,449.151,450.733,455.893,457.813,460.146,464.151,465.733,468.921,473.061,477.043,480.268,484.341,487.513,490.738,494.698,496.281,498.996,501.328,504.561,508.281,510.328,512.226,514.146,516.456,519.351,521.061" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.67,0.53,0.43,0.55,0.55,0.44,0.82,0.37,0.43,0.31,0.31,0.46,0.23,0.23,0.74,0.23,0.23,0.23,0.7,0.51,0.46,0.55,0.51,0.46,0.23,0.23,0.7,0.23,0.23,0.23,0.67,0.44,0.46,0.37,0.43,0.37,0.23,0.23,0.7,0.23,0.23,0.23,0.77,0.43,0.25,0.5,0.23,0.23,0.59,0.23,0.23,0.71,0.23,0.62,0.37,0.51,0.53,0.31,0.23,0.23,0.59,0.23,0.23,0.54,0.23,0.23,0.74,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.37,0.44,0.52,0.43,0.53,0.31,0.27,0.42,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.69,0.27,0.31,0.53,0.23,0.43,0.55,0.53,0.44,0.55,0.42,0.43,0.53,0.23,0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.31,0.46,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 12. Chennamsetty, N., Voynov, V., Kayser, V., Helk, B. &amp; Trout, B. L. Design of therapeutic proteins with enhanced stability. </text>
   <text y="374.96" x="522.643,526.701,531.771,536.586" svgx:width="0.55,0.7,0.66,0.47" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">PNAS</text>
   <text y="374.96" x="540.08" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="374.96" x="541.663,545.413,549.163" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">106</text>
   <text y="374.96" x="552.913,554.623" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, </text>
   <text y="383.457" x="167.623,171.223,174.823,178.423,182.023,185.623,189.523,193.123,196.723,200.323,203.923,207.523,209.053,211.648,215.248,218.848,222.448,226.048,228.643" svgx:width="0.48,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">11937–11942 (2009).</text>
   <text y="391.955" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,171.249,174.951,177.745,183.831,187.023,191.092,195.161,197.093,198.769,200.183,203.329,205.005,206.685,208.099,212.94,216.746,219.541,221.555,223.418,226.527,228.207,229.62,232.73,234.406,235.82,240.968,242.648,244.061,249.364,250.777,255.289,258.443,262.481,266.411,269.235,273.161,275.941,279.08,282.818,284.686,288.26,289.936,291.35,297.998,299.678,301.091,305.896,309.012,311.303,313.28,316.982,321.028,324.325,326.189,327.602,331.529,334.682,337.405,339.381,342.895,346.964,348.377,352.079,354.269,355.682,358.874,362.8,365.091,367.038,370.882,374.741,378.671,380.647,383.801,386.52,387.933,390.232,393.424,396.113,399.529,402.687,404.978,406.954,410.964,414.44,415.854,418.535,422.499,425.69,428.829,430.809,434.787,437.926,439.34,442.494,446.301,448.187,450.396,454.105,458.069,461.223,463.941,465.355,470.481,472.368,474.667,478.638,480.618,484.687,486.101,488.077,492.004,494.296,497.089,499.066,503.074,505.797,507.773,510.934,514.231,516.133,517.944,521.352,522.766,526.693,528.647,531.426,535.127,537.779,541.705,544.859,547.511,550.702,554.662" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.47,0.51,0.37,0.82,0.44,0.55,0.55,0.27,0.23,0.23,0.56,0.23,0.23,0.23,0.69,0.52,0.37,0.27,0.25,0.43,0.23,0.23,0.53,0.23,0.23,0.69,0.23,0.23,0.71,0.23,0.7,0.43,0.55,0.53,0.37,0.53,0.37,0.42,0.51,0.25,0.51,0.23,0.23,0.89,0.23,0.23,0.63,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.31,0.44,0.37,0.47,0.43,0.31,0.27,0.55,0.47,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.37,0.23,0.69,0.27,0.31,0.53,0.27,0.55,0.23,0.27,0.55,0.31,0.37,0.27,0.55,0.37,0.27,0.42,0.44,0.25,0.25,0.46,0.23,0.53,0.27,0.37,0.51,0.37,0.53,0.43,0.37,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 13. Sormanni, P., Aprile, F. A. &amp; Vendruscolo, M. Rational design of antibodies targeting specific epitopes within intrinsically disordered </text>
   <text y="400.452" x="167.623,171.463,174.148,177.89,180.133,183.32,185.33,189.373,192.125,193.835" svgx:width="0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">proteins. </text>
   <text y="400.452" x="195.365,199.498,202.1,205.595,208.46,210.005,215.075,218.585,220.82,222.688,224.233,228.988,231.8,235.423,239.233,240.778,244.333,247.198,249.245,250.79,256.093,259.603" svgx:width="0.55,0.37,0.47,0.38,0.23,0.7,0.49,0.31,0.25,0.23,0.66,0.38,0.49,0.51,0.23,0.47,0.38,0.27,0.23,0.71,0.47,0.66" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Proc Natl Acad Sci USA</text>
   <text y="400.452" x="264.583" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="400.452" x="266.12,269.87,273.62" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">112</text>
   <text y="400.452" x="277.37,279.08,280.61,284.21,287.81,291.41,295.01,298.91,302.51,306.11,309.71,313.31,314.84,317.435,321.035,324.635,328.236,331.836,334.431" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 9902–9907 (2015).</text>
   <text y="408.95" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,171.656,174.855,178.79,181.098,184.368,187.496,190.661,193.391,195.078,196.503,201.285,202.973,204.398,206.525,208.213,209.638,214.948,216.373,222.903,226.104,228.863,232.064,236.119,239.364,242.094,243.781,245.206,250.171,251.859,253.284,258.47,260.158,261.583,267.198,271.02,273.285,278.25,283.67,288.35,290.037,291.462,294.732,296.157,299.582,302.747,306.795,309.96,312.72,316.025,317.9,319.325,322.475,326.186,332.16,335.983,339.851,342.158,345.283,347.582,349.57,353.279,357.335,360.64,362.515,363.94,370.028,373.193,375.5,379.451,383.318,387.255,388.68,390.808,394.517,397.277,398.702,401.009,404.96,408.125,409.55,413.487,416.652,419.382,421.37,424.892,428.972,430.397,434.108,436.305,437.73,440.93,444.865,447.164,449.119,452.971,456.839,460.722,464.142,465.567,468.717,472.427,478.402,482.254,484.129,487.294,493.382,496.547,500.482,502.789,505.99,508.792,510.687,512.972,516.392,517.817,521.755,524.92,527.137,530.302,533.104,539.224,541.212,545.292,547.279,551.296,554.806" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.44,0.55,0.31,0.44,0.42,0.43,0.37,0.23,0.23,0.63,0.23,0.23,0.33,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.44,0.55,0.44,0.37,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,0.75,0.52,0.31,0.67,0.74,0.63,0.23,0.23,0.44,0.23,0.47,0.43,0.55,0.43,0.37,0.44,0.25,0.23,0.42,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.82,0.43,0.31,0.53,0.51,0.53,0.23,0.3,0.51,0.37,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.23,0.53,0.43,0.31,0.43,0.37,0.82,0.27,0.55,0.27,0.55,0.47,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 14. Pantazes, R. J. &amp; Maranas, C. D. OptCDR: a general computational method for the design of antibody complementarity determining </text>
   <text y="417.447" x="167.623,170.308,173.495,177.043,179.053,182.788,186.83,189.583,191.113,193.265,197.0,199.783,201.313,203.645,206.87,209.593,213.043,216.23,218.473,221.697,225.657,227.187,230.375,234.215,236.135,238.377,242.12,246.117,249.305,250.835,254.555,256.565,260.637,264.597,266.607,270.65,274.182,275.892" svgx:width="0.37,0.43,0.47,0.27,0.51,0.55,0.37,0.23,0.3,0.51,0.37,0.23,0.31,0.44,0.37,0.47,0.43,0.31,0.43,0.53,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">regions for targeted epitope binding. </text>
   <text y="417.447" x="277.422,281.555,284.157,287.592,289.82,292.82,294.77,298.76,300.305,304.377,308.27,311.42,312.965,318.327,321.267,323.795,325.34,328.895,331.775" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.23,0.56,0.53,0.42,0.23,0.71,0.4,0.34,0.23,0.47,0.4,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Protein Eng Des Sel</text>
   <text y="417.447" x="333.642" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="417.447" x="335.188,338.938" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">23</text>
   <text y="417.447" x="342.688,344.398,345.928,349.528,353.128,356.728,360.628,364.228,367.828,371.428,372.958,375.553,379.153,382.753,386.353,389.953,392.548" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 849–858 (2010).</text>
   <text y="425.945" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,173.18,176.923,180.77,184.483,186.193,187.769,191.654,193.364" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.77,0.51,0.52,0.52,0.23,0.23,0.62,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 15. Hopp, T. </text>
   <text y="425.945" x="194.938,197.885,200.188,201.778,205.37" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="425.945" x="207.238,208.948,210.523,215.705,217.28,220.003,223.978,227.713,230.57,232.858,234.433,238.43,242.203,244.048,247.49,251.487,254.675,258.522,260.847,262.857,266.817,270.005,271.58,277.7,280.925,283.677,287.352,290.54,293.322,294.897,297.71,300.934,304.691,308.674,311.861,315.934,319.106,322.294,323.869,327.829,330.641,333.829,336.094,340.114,342.012,343.587,345.738,349.474,352.257,353.832,356.517,359.741,362.913,366.648,372.716,376.436,378.446,382.526,385.751,389.711,391.998,393.573,397.413,400.098,403.841,406.083,409.271,411.281,415.383,416.958,418.968,422.928,426.116,430.076,432.401,434.411,438.423,441.618,444.768,447.093,449.103,452.838,456.941,458.516,461.741,465.814,469.773,471.349,475.196,479.179,482.006,484.016,488.029,491.223,494.373,496.698,498.708,502.443,506.545,508.255" svgx:width="0.23,0.23,0.69,0.23,0.37,0.53,0.51,0.37,0.31,0.23,0.52,0.51,0.25,0.46,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.82,0.44,0.37,0.5,0.43,0.37,0.23,0.37,0.43,0.51,0.53,0.43,0.55,0.42,0.43,0.23,0.53,0.37,0.43,0.3,0.53,0.25,0.23,0.3,0.51,0.37,0.23,0.37,0.43,0.42,0.51,0.82,0.51,0.27,0.55,0.44,0.55,0.31,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.27,0.53,0.43,0.55,0.31,0.27,0.54,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.44,0.55,0.53,0.23,0.52,0.53,0.37,0.27,0.54,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. A short polypeptide marker sequence useful for recombinant protein identification and purification. </text>
   <text y="425.945" x="509.83,514.053,516.07,519.595,522.01,525.805,528.76,531.535,535.24,539.178,542.628,544.465,547.99,551.298" svgx:width="0.58,0.27,0.47,0.32,0.6,0.4,0.38,0.51,0.53,0.47,0.25,0.47,0.42,0.44" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Bio/Technology</text>
   <text y="425.945" x="554.613" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="434.442" x="167.623" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">6</text>
   <text y="434.442" x="171.373,173.083,174.613,178.213,181.813,185.413,189.013,192.913,196.513,200.113,203.713,207.313,208.843,211.438,215.038,218.638,222.238,225.838,228.433" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 1204–1210 (1988).</text>
   <text y="442.94" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,172.449,176.443,180.369,183.223,185.372,187.37,191.387,193.199,195.089,199.075,200.886,202.776,206.058,207.869,209.681,211.571,216.727,220.099,222.915,225.341,228.128,231.964,236.138,239.944,243.458,247.167,248.978,250.868,254.528,256.34,258.23,263.663,265.553,270.68,274.757,278.75,281.994,283.805,285.695,289.352,291.163,293.053,296.604,299.03,301.989,306.073,309.399,311.713,315.797,318.583,321.872,323.762,327.598,329.919,331.809,335.136,339.197,341.624,343.735,346.506,350.575,354.779,359.852,365.316,367.206,373.99,377.691,379.581,383.5,386.834,390.746,392.636,396.697,400.533,406.754,410.081,412.193,416.396,418.286,421.613,425.787,429.848,431.738,433.76,436.148,439.006,440.896,444.957,447.871,451.16,453.05,455.165,459.368,461.258,463.692,467.768,471.057,472.947,475.763,478.197,481.531,485.352,487.501,489.5,491.611,494.866,498.117,500.543,502.655,506.491,510.695,512.585,516.422,518.743,520.633,523.922,528.065,531.714,533.826,538.0,541.326,544.618,547.404,550.73,554.69" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.63,0.51,0.51,0.37,0.27,0.25,0.53,0.23,0.23,0.62,0.23,0.23,0.56,0.23,0.23,0.23,0.67,0.44,0.37,0.31,0.37,0.51,0.55,0.51,0.46,0.51,0.23,0.23,0.47,0.23,0.23,0.71,0.23,0.67,0.53,0.51,0.43,0.23,0.23,0.47,0.23,0.23,0.47,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.36,0.53,0.54,0.69,0.71,0.23,0.89,0.48,0.23,0.53,0.44,0.51,0.23,0.53,0.51,0.82,0.44,0.27,0.55,0.23,0.44,0.55,0.53,0.23,0.27,0.31,0.37,0.23,0.53,0.37,0.43,0.23,0.27,0.55,0.23,0.31,0.53,0.43,0.23,0.37,0.31,0.44,0.51,0.27,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.43,0.55,0.47,0.27,0.55,0.43,0.43,0.37,0.43,0.53,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 16. Roosild, T. P., Castronovo, S. &amp; Choe, S. Structure of anti-FLAG M2 Fab domain and its use in the stabilization of engineered </text>
   <text y="451.437" x="167.623,173.735,176.923,182.99,186.71,189.493,192.718,196.79,199.978,201.508,205.348,208.033,211.775,214.018,217.205,219.215,223.258,226.01,227.72" svgx:width="0.82,0.43,0.82,0.51,0.37,0.44,0.55,0.43,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">membrane proteins. </text>
   <text y="451.437" x="229.25,234.005,236.9,239.127,242.802,244.347,249.005,251.9,255.215,257.667,259.895,263.487,265.317,267.155,270.68,273.875,276.62,278.165,281.72,284.675,287.57,289.872,291.417,295.37,296.915,300.341,302.576,305.389,309.356,312.251,314.554,316.099,320.321,322.339,325.789,327.656,329.201,333.86,336.754,340.069,342.521,344.824,346.369,351.154,354.604,360.378,366.154,370.054" svgx:width="0.66,0.38,0.31,0.49,0.23,0.63,0.37,0.44,0.34,0.31,0.49,0.25,0.25,0.47,0.42,0.37,0.23,0.47,0.4,0.38,0.31,0.23,0.53,0.23,0.47,0.31,0.37,0.53,0.38,0.31,0.23,0.58,0.27,0.47,0.25,0.23,0.63,0.37,0.44,0.34,0.31,0.23,0.63,0.47,0.79,0.79,0.53,0.53" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Acta Crystallogr Sect F Struct Biol Cryst Commun</text>
   <text y="451.437" x="374.044" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="451.437" x="375.583,379.333" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">62</text>
   <text y="451.437" x="383.083,384.793,386.323,389.923,393.523,397.123,401.023,404.623,408.223,411.823,413.353,415.948,419.548,423.148,426.748,430.348,432.943" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 835–839 (2006).</text>
   <text y="459.935" x="155.623,155.713,159.313,162.913,164.623,166.34799999999998,167.623,171.77,173.848,177.081,181.026,184.281,187.176,193.364,196.657,200.827,202.604,204.374,209.249,211.027,212.797,216.899,218.677,220.454,222.224,227.167,231.254,233.168,236.648,239.903,242.281,244.058,245.828,248.049,249.827,251.597,256.847,258.624,260.402,262.172,266.499,270.527,272.882,276.099,282.309,284.387,288.497,292.015,295.27,297.648,299.425,301.195,306.258,308.035,309.805,314.86,316.638,318.415,320.185,324.31,327.602,329.636,331.413,333.183,335.404,337.181,338.951,344.006,345.784,347.554,352.954,354.724,361.347,364.572,368.105,372.253,375.545,378.299,382.281,384.059,385.829,388.049,389.827,391.597,396.847,398.624,400.394,405.449,408.518,412.028,414.81,417.211,420.608,422.611,424.576,426.653,429.871,433.088,435.481,437.558,441.361,445.531,447.301,450.497,454.547,457.764,461.83,465.085,467.837,471.64,475.781,479.036,480.806,483.589,485.982,488.832,492.049,494.36,497.615,501.23,503.307,506.562,509.382,511.152,513.372,517.176,520.026,521.796,527.976,531.231,537.366,541.153,544.003,547.296,551.436,554.624" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.54,0.27,0.43,0.51,0.43,0.37,0.82,0.44,0.55,0.23,0.23,0.63,0.23,0.23,0.54,0.23,0.23,0.23,0.67,0.53,0.25,0.46,0.43,0.37,0.23,0.23,0.33,0.23,0.23,0.69,0.23,0.23,0.23,0.57,0.55,0.31,0.42,0.82,0.27,0.55,0.47,0.43,0.37,0.23,0.23,0.67,0.23,0.23,0.67,0.23,0.23,0.23,0.56,0.44,0.27,0.23,0.23,0.33,0.23,0.23,0.67,0.23,0.23,0.71,0.23,0.89,0.44,0.46,0.55,0.44,0.37,0.53,0.23,0.23,0.33,0.23,0.23,0.69,0.23,0.23,0.67,0.37,0.46,0.37,0.31,0.44,0.25,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.42,0.53,0.44,0.52,0.43,0.37,0.51,0.55,0.43,0.23,0.37,0.31,0.37,0.44,0.31,0.43,0.47,0.27,0.43,0.37,0.23,0.3,0.51,0.37,0.23,0.82,0.43,0.82,0.51,0.37,0.44,0.55,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 17. Lieberman, R. L., Culver, J. A., Entzminger, K. C., Pai, J. C. &amp; Maynard, J. A. Crystallization chaperone strategies for membrane </text>
   <text y="468.432" x="167.623,171.463,174.148,177.89,180.133,183.32,185.33,189.373,192.125,193.835" svgx:width="0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">proteins. </text>
   <text y="468.432" x="195.365,201.71,204.658,206.893,210.673,214.168,218.008" svgx:width="0.88,0.4,0.31,0.51,0.47,0.51,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Methods</text>
   <text y="468.432" x="220.535" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="468.432" x="222.065,225.815" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">55</text>
   <text y="468.432" x="229.565,231.275,232.805,236.405,240.005,243.605,247.505,251.105,254.705,258.305,259.835,262.43,266.03,269.63,273.23,276.831,279.426" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 293–302 (2011).</text>
   <text y="476.93" x="155.615,155.705,159.305,162.905,164.615,166.34,167.615,171.718,174.965,178.408,181.205,184.355,186.687,190.692,192.402,193.857,198.845,200.555,202.01,206.27,207.98" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.54,0.43,0.46,0.37,0.44,0.31,0.53,0.23,0.23,0.67,0.23,0.23,0.57,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 18. Leysath, C. E. </text>
   <text y="476.93" x="209.435,212.383,214.685,216.155,219.747" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="476.93" x="221.623,223.333,224.788,229.775,232.775,236.218,238.933,241.265,244.595,246.492,247.947,250.661,252.986,255.844,259.826,263.051,265.264,269.246,271.931,275.119,276.574,280.308,282.528,283.983,286.316,290.291,293.478,294.933,298.121,302.163,305.711,307.721,311.793,315.018,318.206,320.891,324.115,328.075,329.53,333.602,336.79,340.682,343.008,345.79,349.12,351.018,353.028,356.178,358.188,362.229,365.739,367.194,370.42,374.379,376.704,378.684,382.562,386.454,390.362,393.804,395.259,401.942,405.542,409.142,410.597,413.769,417.504,423.504,427.382,429.279,432.467,435.947,439.172,443.132,444.587,446.829,450.654,452.109,456.069,459.804,465.924,469.149,471.159,475.262,476.717,480.317,481.772,485.507,487.727,489.182,491.514,495.489,498.677,500.132,503.357,507.317,509.649,513.654,516.437,519.729,523.269,524.724,528.564,531.249,534.992,537.234,540.459,543.683,546.008,547.966,551.378,554.566" svgx:width="0.23,0.23,0.67,0.37,0.46,0.37,0.31,0.44,0.25,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.43,0.55,0.47,0.27,0.55,0.43,0.43,0.37,0.43,0.53,0.23,0.55,0.43,0.53,0.31,0.37,0.44,0.25,0.27,0.42,0.27,0.55,0.47,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.89,0.48,0.48,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.47,0.43,0.53,0.23,0.31,0.51,0.23,0.53,0.51,0.82,0.44,0.27,0.55,0.23,0.48,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.53,0.37,0.44,0.47,0.23,0.52,0.37,0.51,0.31,0.43,0.42,0.31,0.27,0.46,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Crystal structure of the engineered neutralizing antibody M18 complexed to domain 4 of the anthrax protective </text>
   <text y="485.427" x="167.615,170.84,174.8,177.125,179.135,182.585,185.773,189.875,191.585" svgx:width="0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">antigen. </text>
   <text y="485.427" x="193.115,195.523,197.068,203.413,206.863,208.73,210.275,214.498,216.515,219.965" svgx:width="0.32,0.23,0.88,0.47,0.25,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">J Mol Biol</text>
   <text y="485.427" x="221.833" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="485.427" x="223.363,227.113,230.863" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">387</text>
   <text y="485.427" x="234.613,236.323,237.853,241.453,245.053,248.653,252.553,256.153,259.753,263.353,264.883,267.478,271.078,274.678,278.278,281.878,284.473" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 680–693 (2009).</text>
   <text y="493.925" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.637,174.833,178.765,181.069,184.331,187.451,190.609,193.331,195.011,196.429,201.208,202.888,204.305,206.429,208.109,209.789,211.207,216.48,219.279,221.238,224.022,227.241,232.29,236.153,240.017,243.904,245.584,247.001,253.654,255.334,256.751,258.875,260.555,262.235,263.653,267.704,269.641,271.321,272.738,276.595,278.275,279.955,281.372,286.646,288.626,292.738,296.444,299.101,302.987,304.667,306.085,311.627,313.307,314.725,317.876,319.556,320.974,326.276,327.694,334.22,337.416,340.169,343.365,347.417,350.658,353.381,355.061,356.478,361.436,363.116,364.533,369.717,371.397,372.815,380.789,383.946,385.364,387.599,389.814,392.971,395.724,398.845,401.142,403.071,406.455,409.612,411.03,415.156,417.813,421.527,423.74,426.897,428.877,432.95,434.367,439.064,442.26,446.19,449.348,452.07,454.05,457.569,461.642,463.059,466.256,470.3,474.23,475.647,481.259,485.078,487.374,489.354,495.467,497.447,500.567,503.688,505.985,507.965,511.671,515.744,517.161,519.726,522.254,526.41,531.024,536.596,539.161,540.579,543.265,547.218,549.109,551.323,554.511" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.44,0.55,0.31,0.44,0.42,0.43,0.37,0.23,0.23,0.63,0.23,0.23,0.33,0.23,0.23,0.23,0.71,0.37,0.27,0.37,0.43,0.69,0.51,0.51,0.53,0.23,0.23,0.89,0.23,0.23,0.33,0.23,0.23,0.23,0.54,0.27,0.23,0.23,0.62,0.23,0.23,0.23,0.71,0.27,0.56,0.51,0.37,0.53,0.23,0.23,0.74,0.23,0.23,0.56,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.44,0.55,0.44,0.37,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,1.07,0.43,0.23,0.34,0.31,0.43,0.37,0.44,0.31,0.27,0.46,0.43,0.23,0.56,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.63,0.43,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.44,0.55,0.53,0.23,0.75,0.52,0.31,0.27,0.82,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.35,0.34,0.56,0.63,0.75,0.35,0.23,0.37,0.53,0.27,0.31,0.43,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 19. Pantazes, R. J., Grisewood, M. J., Li, T., Gifford, N. P. &amp; Maranas, C. D. The Iterative Protein Redesign and Optimization (IPRO) suite </text>
   <text y="502.422" x="167.608,171.343,173.563,175.093,178.933,181.618,185.443,188.99,191.772,194.997,201.08,203.832,205.542" svgx:width="0.51,0.3,0.23,0.52,0.37,0.51,0.47,0.37,0.44,0.82,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">of programs. </text>
   <text y="502.422" x="207.072,209.262,212.712,216.612,219.425,223.362,226.955,228.821,230.366,233.809,235.841,237.386,240.199,243.649,249.431,253.001,256.893,259.121,262.631,264.866,266.883,270.333,274.271,277.863,279.731,281.276,284.051,287.83,290.83,296.605,298.683,301.135,303.37,306.265" svgx:width="0.32,0.47,0.53,0.37,0.53,0.49,0.25,0.23,0.47,0.27,0.23,0.38,0.47,0.79,0.49,0.53,0.31,0.49,0.31,0.27,0.47,0.53,0.49,0.25,0.23,0.38,0.51,0.4,0.79,0.27,0.34,0.31,0.37,0.44" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Journal of computational chemistry</text>
   <text y="502.422" x="309.59" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="502.422" x="311.12,314.87" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">36</text>
   <text y="502.422" x="318.62,320.33,321.86,325.46,329.06,332.66,336.56,340.16,343.76,347.36,348.89,351.485,355.085,358.685,362.285,365.885,368.48" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 251–263 (2015).</text>
   <text y="510.92" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.69,174.941,176.93,178.663,180.305,182.483,184.216,185.858,190.868,192.601" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.44,0.27,0.23,0.23,0.33,0.23,0.23,0.67,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 20. Pai, J. C. </text>
   <text y="510.92" x="194.243,197.216,199.544,201.202,204.817" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="510.92" x="206.72,208.453,210.095,215.22,218.981,222.935,226.373,229.583,232.346,235.121,237.153,240.913,245.038,246.68,250.441,252.683,254.326,257.163,260.358,264.329,267.824,269.466,273.488,276.698,280.571,282.921,284.954,288.936,292.146,294.839,298.584,300.617,304.714,308.696,310.729,314.796,318.329,319.971,322.712,326.734,329.984,333.179,335.211,339.246,342.441,344.386,346.722,350.187,351.829,354.006,357.767,360.572,362.214,365.409,368.434,371.899,374.639,376.997,380.352,382.272,383.914,387.067,391.074,394.249,398.271,401.481,404.191,407.952,412.049,415.259,416.901,420.884,424.157,427.594,430.776,432.696,436.464,440.328,446.466,449.676,453.661,455.971,457.704" svgx:width="0.23,0.23,0.67,0.51,0.55,0.46,0.43,0.37,0.37,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.37,0.42,0.53,0.46,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.36,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.27,0.31,0.46,0.23,0.3,0.51,0.37,0.23,0.42,0.37,0.46,0.37,0.31,0.44,0.25,0.23,0.42,0.53,0.44,0.52,0.43,0.37,0.51,0.55,0.43,0.23,0.53,0.43,0.46,0.43,0.25,0.51,0.52,0.82,0.43,0.55,0.31,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Conversion of scFv peptide-binding specificity for crystal chaperone development. </text>
   <text y="510.92" x="459.346,463.503,466.131,469.592,471.844,474.866,476.842,480.854,482.512,486.61,490.528,493.7,495.358,500.745,503.711,506.261,507.918,511.498,514.403" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.23,0.56,0.53,0.42,0.23,0.71,0.4,0.34,0.23,0.47,0.4,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Protein Eng Des Sel</text>
   <text y="510.92" x="516.293" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="510.92" x="518.03,521.803" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">24</text>
   <text y="510.92" x="525.576,527.308,528.951,532.573,536.195,539.818,543.74,547.363,550.985,554.585" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 419–428 </text>
   <text y="519.417" x="167.608,170.203,173.803,177.403,181.003,184.603,187.198" svgx:width="0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">(2011).</text>
   <text y="527.915" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,172.678,176.436,180.254,183.374,187.326,190.859,194.834,196.514,197.931,202.889,204.569,205.986,212.159,213.839,215.519,216.936,222.111,223.979,230.069,233.294,236.813,239.468,243.045,244.725,246.143,248.265,249.945,251.363,256.32,258.0,259.68,261.098,265.051,268.846,272.326,275.108,278.814,282.887,284.567,285.984,292.637,294.317,295.997,297.414,299.695,303.077,306.235,308.943,311.726,315.431,319.503,321.183,322.601,326.853,328.533,329.951,335.253,336.671,342.063,345.258,348.964,351.656,355.174,357.154,360.867,364.774,366.454,367.872,373.204,374.884,376.302,379.707,383.142,387.072,389.376,393.321,396.478,398.773,400.753,403.896,405.313,408.509,412.439,414.734,416.685,420.532,424.395,428.273,431.685,433.103,434.97,436.921,440.611,443.364,446.559,449.357,451.337,454.494,457.217,458.634,460.757,464.62,467.814,471.745,474.528,477.723,481.653,483.07,485.283,488.958,494.065,497.26,499.916,503.824,506.546,507.964,511.932,515.089,518.907,521.202,523.182,527.112,530.269,531.687,533.554,535.534,539.014,542.21,546.252,550.161,552.883,554.593" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.67,0.51,0.51,0.44,0.53,0.47,0.53,0.23,0.23,0.67,0.23,0.23,0.97,0.23,0.23,0.23,0.69,0.25,0.82,0.44,0.47,0.37,0.51,0.23,0.23,0.33,0.23,0.23,0.67,0.23,0.23,0.23,0.56,0.51,0.47,0.37,0.51,0.55,0.23,0.23,0.89,0.23,0.23,0.23,0.34,0.46,0.43,0.37,0.37,0.51,0.55,0.23,0.23,0.59,0.23,0.23,0.71,0.23,0.71,0.43,0.51,0.37,0.47,0.27,0.51,0.53,0.23,0.23,0.71,0.23,0.23,0.47,0.46,0.55,0.31,0.53,0.43,0.31,0.27,0.42,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.25,0.27,0.51,0.37,0.44,0.37,0.27,0.43,0.37,0.23,0.3,0.51,0.42,0.53,0.37,0.43,0.53,0.23,0.31,0.51,0.69,0.44,0.37,0.53,0.37,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 21. Cobaugh, C. W., Almagro, J. C., Pogson, M., Iverson, B. &amp; Georgiou, G. Synthetic antibody libraries focused towards peptide ligands. </text>
   <text y="536.412" x="167.608,170.015,171.56,177.905,181.355,183.223,184.768,188.99,191.008,194.458" svgx:width="0.32,0.23,0.88,0.47,0.25,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">J Mol Biol</text>
   <text y="536.412" x="196.325" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="536.412" x="197.855,201.605,205.355" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">378</text>
   <text y="536.412" x="209.105,210.815,212.345,215.945,219.545,223.145,227.045,230.645,234.245,237.846,239.376,241.971,245.571,249.171,252.771,256.371,258.966" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 622–633 (2008).</text>
   <text y="544.91" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,169.958,173.77,177.812,181.895,184.747,188.522,192.662,194.409,196.082,198.274,200.021,201.694,205.766,207.514" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.33,0.51,0.53,0.55,0.37,0.51,0.55,0.23,0.23,0.33,0.23,0.23,0.54,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 22. Johnson, J. L. </text>
   <text y="544.91" x="209.186,212.174,214.517,216.204,219.834" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="544.91" x="221.758,223.505,225.178,228.668,231.032,233.93,237.95,241.214,243.467,247.487,250.307,253.677,255.612,257.285,260.549,264.662,268.66,270.332,274.093,276.14,279.923,283.84,287.713,291.193,293.983,296.03,299.265,302.635,304.57,306.242,309.41,313.432,316.697,319.517,322.847,326.111,328.394,331.619,334.486,336.533,339.721,342.911,345.275,347.323,351.098,355.238,356.91,360.685,362.942,364.615,367.88,372.02,373.692,376.917,380.797,382.757,385.039,388.822,392.859,396.084,398.792,401.546,405.584,408.848,412.058,414.106,418.156,421.366,423.038,426.263,430.346,433.933,435.98,440.093,443.358,446.583,449.308,452.573,456.57,458.243,462.1,465.372,469.22,470.892,473.227,476.047,479.342,482.929,489.081,492.306,496.307,498.632,500.304,503.569,507.682,511.679,513.352,516.562,520.337,526.377,530.294,532.229,535.454,539.032,542.222,544.587,546.635,550.409,554.512" svgx:width="0.23,0.23,0.47,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.44,0.25,0.23,0.44,0.55,0.53,0.23,0.51,0.27,0.51,0.52,0.53,0.46,0.37,0.27,0.42,0.44,0.25,0.23,0.42,0.53,0.44,0.37,0.44,0.42,0.31,0.43,0.37,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.36,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.43,0.55,0.47,0.27,0.55,0.43,0.43,0.37,0.43,0.53,0.23,0.53,0.44,0.51,0.23,0.3,0.37,0.44,0.47,0.82,0.43,0.55,0.31,0.23,0.44,0.55,0.53,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.47,0.44,0.31,0.27,0.51,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation </text>
   <text y="553.407" x="167.608,172.768,174.688,177.02,181.025,182.555,188.667,191.855,197.922,201.642,204.425,207.65,211.722,214.91,216.44,220.28,222.965,226.707,228.95,232.137,234.147,238.189,240.941,242.651,244.181,246.191,252.191,256.069,257.966,259.976,263.171,266.321,268.646,270.656,274.391,278.433,281.186,282.716,284.868,288.603,291.386,292.916,296.088,299.913,302.583,305.756,308.756,312.198,314.913,317.246,320.576,322.511,324.408,326.418,329.568,332.718,335.043,337.053,340.788,344.891,346.601" svgx:width="0.69,0.27,0.31,0.53,0.23,0.82,0.43,0.82,0.51,0.37,0.44,0.55,0.43,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.23,0.27,0.82,0.52,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.3,0.51,0.37,0.23,0.42,0.51,0.36,0.42,0.37,0.46,0.37,0.31,0.44,0.25,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">with membrane proteins: implications for co-crystallization. </text>
   <text y="553.407" x="348.131,352.886,355.78,358.008,361.683,363.228,367.886,370.781,374.096,376.548,378.776,382.368,384.198,386.036,389.561,392.756,395.501,397.046,402.356,403.901,408.123,410.141,413.591,415.458,417.003,421.661,424.556,427.871,430.323,432.551,436.143,437.973,439.81,443.335,446.53" svgx:width="0.66,0.38,0.31,0.49,0.23,0.63,0.37,0.44,0.34,0.31,0.49,0.25,0.25,0.47,0.42,0.37,0.23,0.71,0.23,0.58,0.27,0.47,0.25,0.23,0.63,0.37,0.44,0.34,0.31,0.49,0.25,0.25,0.47,0.42,0.37" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Acta Crystallogr D Biol Crystallogr</text>
   <text y="553.407" x="449.275" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="553.407" x="450.823,454.573" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">71</text>
   <text y="553.407" x="458.323,460.033,461.563,465.163,468.763,472.363,476.263,479.863,483.463,487.063,488.593,491.188,494.788,498.388,501.988,505.588,508.183" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 896–906 (2015).</text>
   <text y="561.905" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.755,174.913,180.073,182.758,185.945,190.018,193.19,196.333,198.043,199.573,206.255,207.965,209.495,214.483,216.193,217.723,223.055,224.585,229.685,233.458,235.356,241.475,244.7,248.802,250.512,252.042,255.222,256.932,258.462,265.145,266.855,268.385,271.895,275.877,279.027,283.025,286.212,287.742,290.915,294.65,300.65,304.527,306.425,309.612,315.725,318.912,322.871,325.204,328.43,331.257,333.177,335.487,338.929,340.459,343.609,345.897,347.427,351.267,353.952,357.694,359.937,363.124,365.134,369.237,371.719,375.559,378.244,381.987,384.229,387.417,389.427,393.529,395.059,397.069,401.029,403.272,406.459,409.286,411.506,414.798,417.971,421.158,423.911,425.621" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.54,0.44,0.69,0.37,0.43,0.55,0.42,0.43,0.23,0.23,0.89,0.23,0.23,0.67,0.23,0.23,0.71,0.23,0.67,0.51,0.25,0.82,0.44,0.55,0.23,0.23,0.56,0.23,0.23,0.89,0.23,0.23,0.47,0.53,0.44,0.52,0.43,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.23,0.44,0.31,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.33,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.27,0.55,0.31,0.43,0.37,0.3,0.44,0.42,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 23. Lawrence, M. C. &amp; Colman, P. M. Shape complementarity at protein/protein interfaces. </text>
   <text y="561.905" x="427.151,429.558,431.103,437.448,440.898,442.766,444.311,448.533,450.551,454.001" svgx:width="0.32,0.23,0.88,0.47,0.25,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">J Mol Biol</text>
   <text y="561.905" x="455.893" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="561.905" x="457.423,461.173,464.923" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">234</text>
   <text y="561.905" x="468.673,470.383,471.913,475.513,479.113,482.713,486.613,490.213,493.813,497.413,498.943,501.538,505.138,508.738,512.338,515.938,518.533" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 946–950 (1993).</text>
   <text y="570.402" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,172.352,176.429,179.208,183.195,187.271,190.661,192.469,194.329,199.636,201.44,203.3,208.73,210.59,215.987,218.867,222.118,225.107,226.915,228.775,231.022,232.829,234.689,236.936,238.743,240.603,244.208,248.285,251.529,255.62,258.905,260.765,264.035,267.864,273.959,277.931,279.922,283.207,289.414,292.695,296.75,299.177,302.495,305.417,307.432,309.836,313.376,315.236,318.555,322.722,326.776,328.636,332.562,336.039,340.097,342.876,346.795,350.339,353.624,357.821,359.681,363.652,367.481,371.648,375.702,377.562,381.496,384.275,387.56,389.807,393.092,395.871,399.152,403.319,406.589,409.871,412.721,414.581,416.688,420.888,422.748,426.682,429.461,433.298,435.635,438.917,441.024,445.224,447.988,451.922,454.702,458.539,460.875,464.16,466.268,470.464,472.324,474.432,478.486,480.823,484.104,487.026,489.34,492.73,496.0,499.281,502.131,503.939,505.799,507.906,514.0,517.972,519.967,522.071,525.36,528.604,531.024,533.131,536.961,541.097,543.947,545.807,548.054,551.883,554.665" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.67,0.53,0.37,0.51,0.53,0.44,0.23,0.23,0.74,0.23,0.23,0.71,0.23,0.71,0.37,0.44,0.46,0.23,0.23,0.33,0.23,0.23,0.33,0.23,0.23,0.47,0.53,0.44,0.52,0.43,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.23,0.44,0.55,0.53,0.23,0.53,0.46,0.53,0.37,0.51,0.47,0.43,0.55,0.23,0.51,0.51,0.55,0.53,0.23,0.52,0.37,0.43,0.3,0.43,0.37,0.43,0.55,0.42,0.43,0.37,0.23,0.27,0.55,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.36,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.27,0.55,0.31,0.43,0.37,0.3,0.44,0.42,0.43,0.37,0.23,0.23,0.27,0.82,0.52,0.25,0.27,0.42,0.44,0.31,0.27,0.51,0.55,0.37,0.23,0.3,0.51,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 24. Kuroda, D. &amp; Gray, J. J. Shape complementarity and hydrogen bond preferences in protein-protein interfaces: implications for </text>
   <text y="578.9" x="167.608,170.833,174.793,177.118,179.098,182.975,186.867,190.775,194.218,195.748,201.86,205.753,209.713,212.87,214.768,216.778,220.82,224.33,225.86,229.085,233.159,237.119,238.649,242.489,245.174,248.916,251.159,254.346,256.356,260.459,263.129,266.969,269.654,273.396,275.639,278.826,280.836,284.939,286.469,290.429,294.321,297.449,301.221,303.231,307.274,310.806,312.516" svgx:width="0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.82,0.51,0.53,0.43,0.25,0.27,0.55,0.47,0.23,0.44,0.55,0.53,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.36,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.53,0.51,0.42,0.5,0.27,0.55,0.47,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">antibody modeling and protein-protein docking. </text>
   <text y="578.9" x="314.046,318.268,320.286,323.736,325.686,329.601,331.558,335.008,337.821,343.671,347.181,349.416,351.433,354.297" svgx:width="0.58,0.27,0.47,0.27,0.53,0.27,0.47,0.37,0.79,0.49,0.31,0.27,0.38,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Bioinformatics</text>
   <text y="578.9" x="356.833" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="578.9" x="358.363,362.113" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">32</text>
   <text y="578.9" x="365.863,367.573,369.103,372.703,376.303,379.903,383.503,387.403,391.003,394.603,398.203,401.803,403.333,405.928,409.528,413.128,416.728,420.328,422.923" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 2451–2456 (2016).</text>
   <text y="587.397" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,172.542,175.721,179.734,182.058,188.207,191.462,195.594,199.727,201.467,203.113,209.825,211.565" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.67,0.44,0.53,0.3,0.82,0.44,0.55,0.55,0.23,0.23,0.89,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 25. Kaufmann, M. </text>
   <text y="587.397" x="213.208,216.185,218.517,220.178,223.801" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="587.397" x="225.695,227.435,229.085,234.103,237.131,240.604,243.348,245.711,249.069,250.997,252.647,255.391,257.745,260.632,264.644,267.899,270.14,274.153,276.867,280.085,281.735,285.499,287.749,289.395,291.757,295.761,298.979,300.629,303.883,307.872,310.227,312.267,314.967,320.621,322.638,325.42,327.066,329.428,332.712,336.252,337.902,341.157,345.146,347.5,349.509,353.416,357.338,361.275,364.747,366.393,370.023,375.566,379.196,380.846,383.628,385.668,389.74,393.332,395.259,398.477,401.177,404.334,408.345,411.6,413.64,417.772,419.418,421.743,424.555,427.839,431.416,437.558,440.775,444.765,447.082,448.728,451.931,455.695,461.724,465.631,467.559,470.776,474.285,477.54,481.53,483.18,485.451,489.306,490.953,492.902,495.219,498.002,499.648,502.903,506.892,509.247,511.287,514.767,517.984,522.117,523.857" svgx:width="0.23,0.23,0.67,0.37,0.46,0.37,0.31,0.44,0.25,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.44,0.55,0.31,0.27,0.36,0.77,0.27,0.37,0.23,0.31,0.44,0.47,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.48,0.74,0.48,0.23,0.37,0.27,0.55,0.47,0.25,0.43,0.36,0.42,0.53,0.44,0.27,0.55,0.23,0.3,0.37,0.44,0.47,0.82,0.43,0.55,0.31,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.47,0.43,0.53,0.23,0.31,0.51,0.23,0.27,0.31,0.37,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen. </text>
   <text y="587.397" x="525.507,527.943,529.605,535.98,539.46,541.356,543.018,547.269,549.317,552.797" svgx:width="0.32,0.23,0.88,0.47,0.25,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">J Mol Biol</text>
   <text y="587.397" x="554.608" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="595.895" x="167.608,171.358,175.108" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">318</text>
   <text y="595.895" x="178.858,180.568,182.098,185.698,189.298,192.898,196.798,200.398,203.998,207.598,209.128,211.723,215.323,218.923,222.523,226.123,228.718" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 135–147 (2002).</text>
   <text y="604.392" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,174.163,177.388,180.073,183.268,186.418,188.743,190.79,192.687,194.652,196.362,197.892,201.072,202.782,204.492,206.022,210.747,214.572,217.325,219.29,221.0,222.53,227.712,229.422,230.952,236.285,237.815,241.82,244.602,247.827,253.939,257.674,261.634,263.967,267.192,271.264,274.872,276.582,278.112,283.294,285.004,286.534,290.719,293.187,298.549,302.104,303.814,305.344,308.494,312.387,314.629,318.364,324.484,327.633,329.958,331.968,335.141,336.671,340.511,343.196,346.421,350.381,352.391,355.616,357.941,359.951,363.686,367.788,369.318,373.053,375.273,376.803,380.028,383.988,386.313,388.293,392.17,396.063,399.97,403.413,404.943,407.658,409.983,412.839,416.822,420.047,422.259,426.242,428.927,432.114,434.867,436.577" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.89,0.44,0.37,0.42,0.44,0.31,0.27,0.25,0.27,0.23,0.23,0.56,0.23,0.23,0.23,0.63,0.51,0.37,0.27,0.23,0.23,0.69,0.23,0.23,0.71,0.23,0.62,0.37,0.44,0.82,0.51,0.55,0.31,0.44,0.55,0.51,0.23,0.23,0.69,0.23,0.23,0.56,0.34,0.71,0.47,0.23,0.23,0.44,0.53,0.31,0.51,0.82,0.44,0.31,0.27,0.42,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 26. Marcatili, P., Rosi, A. &amp; Tramontano, A. PIGS: automatic prediction of antibody structures. </text>
   <text y="604.392" x="438.107,442.329,444.347,447.797,449.747,453.662,455.619,459.069,461.882,467.732,471.242,473.477,475.495,478.36" svgx:width="0.58,0.27,0.47,0.27,0.53,0.27,0.47,0.37,0.79,0.49,0.31,0.27,0.38,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Bioinformatics</text>
   <text y="604.392" x="480.913" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="604.392" x="482.443,486.193" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">24</text>
   <text y="604.392" x="489.943,491.653,493.183,496.783,500.383,503.983,507.583,511.483,515.083,518.683,522.283,525.883,527.413,530.008,533.608,537.208,540.808,544.408,547.003" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 1953–1954 (2008).</text>
   <text y="612.89" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.59,175.483,179.308,182.105,185.33,188.082,190.002,193.295,195.005,196.537,200.729,202.439,207.802,209.512" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.51,0.51,0.37,0.44,0.37,0.25,0.44,0.23,0.23,0.7,0.23,0.71,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 27. Poosarla, V.G. </text>
   <text y="612.89" x="211.04,213.988,216.29,217.835,221.428" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="612.89" x="223.295,225.005,226.535,231.635,235.37,241.37,245.218,249.11,251.442,254.592,256.917,258.927,262.662,266.742,270.072,271.97,273.5,277.46,280.647,282.177,286.249,289.954,293.367,297.192,298.722,302.682,305.869,308.622,310.632,314.179,318.282,319.812,323.547,325.767,327.297,330.522,334.482,336.807,338.787,342.665,346.557,350.517,352.527,355.715,358.467,359.997,363.717,365.727,369.8,373.76,375.77,379.812,383.322,384.852,387.095,390.92,392.45,395.742,397.272,401.27,404.457,408.305,410.63,412.64,416.6,419.787,421.317,426.477,428.397,430.73,434.735,436.265,440.27,442.28,445.843,449.848,451.378,454.603,460.588,464.69,466.61,468.92,471.815,473.525" svgx:width="0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.23,0.55,0.51,0.46,0.51,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.31,0.51,0.23,0.44,0.23,0.52,0.43,0.52,0.31,0.27,0.53,0.43,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.47,0.53,0.23,0.44,0.8,0.55,0.27,0.31,0.46,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Computational de novo design of antibodies binding to a peptide with high affinity. </text>
   <text y="612.89" x="475.055,479.278,481.295,484.73,486.958,489.913,492.688,496.392,500.329,503.779,505.647,507.192,511.414,513.432,516.927,519.927,523.819" svgx:width="0.58,0.27,0.47,0.31,0.4,0.38,0.51,0.53,0.47,0.25,0.23,0.58,0.27,0.47,0.4,0.53,0.42" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Biotechnol Bioeng</text>
   <text y="612.89" x="527.0,528.531,531.125,534.725,538.325,541.925,545.525,548.12" svgx:width="0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> (2017).</text>
   <text y="621.387" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.754,175.067,179.115,181.535,184.918,188.158,191.436,194.278,196.078,197.915,202.811,204.611,206.448,208.689,210.489,212.289,214.127,219.518,222.433,224.509,227.41,230.745,235.911,239.891,243.872,247.875,249.675,251.513,258.285,260.085,261.923,264.163,265.963,267.8,273.223,275.06,281.704,285.017,287.89,291.203,295.371,298.73,301.572,303.372,305.21,310.287,312.087,313.925,319.226,321.026,322.863,327.676,330.989,334.252,337.529,341.577,343.955,345.792,349.175,353.171,356.733,360.047,364.207,367.47,370.747,373.59,375.427,377.527,381.72,383.557,386.82,390.643,396.731,400.667,404.648,407.068,410.307,412.719,414.819,418.642,422.811,426.228,428.216,430.053,433.982,436.755,440.586,442.917,446.194,448.294,452.487,454.324,458.374,461.652,464.494,466.594,470.23,474.423,476.223" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.44,0.55,0.31,0.44,0.42,0.43,0.37,0.23,0.23,0.63,0.23,0.23,0.33,0.23,0.23,0.23,0.71,0.37,0.27,0.37,0.43,0.69,0.51,0.51,0.53,0.23,0.23,0.89,0.23,0.23,0.33,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.44,0.55,0.44,0.37,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,0.63,0.43,0.42,0.43,0.55,0.31,0.23,0.44,0.53,0.46,0.44,0.55,0.42,0.43,0.37,0.23,0.27,0.55,0.23,0.42,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 28. Pantazes, R. J., Grisewood, M. J. &amp; Maranas, C. D. Recent advances in computational protein design. </text>
   <text y="621.387" x="478.06,482.807,486.795,489.697,492.532,494.388,499.84,503.499,505.538,509.618,511.478,514.995,517.318,520.22,524.276,527.26,529.653,531.513,535.824,537.931,541.47" svgx:width="0.63,0.53,0.37,0.37,0.23,0.71,0.49,0.27,0.53,0.23,0.47,0.31,0.37,0.53,0.38,0.31,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Curr Opin Struct Biol</text>
   <text y="621.387" x="543.427" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="621.387" x="545.225,549.058" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">21</text>
   <text y="621.387" x="552.891,554.601" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, </text>
   <text y="629.885" x="167.608,171.208,174.808,178.408,182.308,185.908,189.508,193.108,194.638,197.233,200.833,204.433,208.033,211.633,214.228" svgx:width="0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">467–472 (2011).</text>
   <text y="638.382" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,172.115,174.125,178.151,182.028,185.216,187.937,191.469,193.179,194.627,199.614,201.324,202.772,207.032,208.742" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.62,0.27,0.55,0.51,0.43,0.37,0.47,0.23,0.23,0.67,0.23,0.23,0.57,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 29. Tinberg, C. E. </text>
   <text y="638.382" x="210.189,213.136,215.438,216.9,220.493" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="638.382" x="222.35,224.06,225.508,230.606,234.341,240.34,244.187,248.079,250.411,253.56,255.884,257.894,261.629,265.708,269.037,270.935,272.382,276.342,279.53,282.282,284.292,287.839,291.941,293.389,297.123,299.343,300.791,302.688,304.698,308.208,311.433,315.504,319.464,322.134,325.854,327.864,331.935,335.895,337.905,341.947,345.457,346.905,350.744,353.428,357.17,359.412,362.599,364.609,368.651,371.403,372.851,378.01,379.929,382.261,386.266,387.714,391.719,393.729,397.29,401.295,402.743,405.967,411.952,416.055,417.974,420.283,423.726,425.173,428.398,432.469,436.429,437.877,440.688,443.845,445.742,448.966,452.19,454.515,456.471,459.966,461.885,464.194,467.089,468.799" svgx:width="0.23,0.23,0.67,0.51,0.82,0.52,0.53,0.31,0.44,0.31,0.27,0.51,0.55,0.44,0.25,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.25,0.27,0.47,0.44,0.55,0.53,0.36,0.51,0.27,0.55,0.53,0.27,0.55,0.47,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.37,0.23,0.69,0.27,0.31,0.53,0.23,0.53,0.27,0.47,0.53,0.23,0.44,0.8,0.55,0.27,0.31,0.46,0.23,0.44,0.55,0.53,0.23,0.37,0.43,0.25,0.43,0.42,0.31,0.27,0.46,0.27,0.31,0.46,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Computational design of ligand-binding proteins with high affinity and selectivity. </text>
   <text y="638.382" x="470.246,475.316,478.825,481.06,484.959,487.561" svgx:width="0.7,0.49,0.31,0.53,0.37,0.4" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nature</text>
   <text y="638.382" x="490.528" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="638.382" x="491.975,495.725,499.475" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">501</text>
   <text y="638.382" x="503.225,504.935,506.383,509.983,513.583,517.183,521.083,524.683,528.283,531.883,533.33,535.925,539.525,543.125,546.725,550.325,552.92" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 212–216 (2013).</text>
   <text y="646.88" x="155.615,155.705,159.305,162.905,164.615,166.34,167.615,171.755,173.78,175.55,177.29,181.235,183.005,184.775,186.515,190.654,192.679,194.449,196.189,201.994,203.764,205.534,207.274,211.226,214.511,218.613,222.204,223.974,225.714,228.917,230.687,232.457,234.197,237.766,243.969,245.948,248.34,252.405,255.135,260.497,262.604,264.598,266.511,268.281,270.021,273.636,275.406,277.146,279.358,281.128,282.868,288.26,290.0,296.615,299.9,302.786,304.766,308.809,312.019,315.229,318.581,320.351,322.091,326.958,328.728,330.468,335.711,337.481,339.221,344.186,346.916,349.758,352.976,356.478,358.218,361.031,365.17,368.38,372.37,375.152,379.187,382.989,385.337,388.149,389.889,393.684,395.964,397.704,400.096,404.13,407.378,409.118,415.297,418.507,420.779,424.821,427.664,430.873,433.258,435.328,439.123,443.286,445.026,448.821,451.101,452.841,456.126,460.288,462.028,465.313,469.332,471.717,473.757,477.693,481.646,485.613,489.115,490.855,493.6,496.848,499.622,503.678,507.474,511.575,514.448,517.695,519.435,521.738,525.623,527.363,530.715,532.455,536.354,539.099,542.901,545.204,548.451,550.521,554.624" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.54,0.27,0.23,0.23,0.63,0.23,0.23,0.23,0.54,0.27,0.23,0.23,0.77,0.23,0.23,0.23,0.63,0.44,0.55,0.47,0.23,0.23,0.53,0.23,0.23,0.23,0.47,0.82,0.27,0.31,0.53,0.36,0.71,0.27,0.25,0.25,0.23,0.23,0.47,0.23,0.23,0.33,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.27,0.53,0.42,0.42,0.44,0.23,0.23,0.63,0.23,0.23,0.69,0.23,0.23,0.65,0.36,0.37,0.44,0.46,0.23,0.37,0.55,0.44,0.52,0.37,0.53,0.51,0.31,0.37,0.23,0.51,0.3,0.23,0.31,0.53,0.43,0.23,0.82,0.44,0.31,0.53,0.37,0.44,0.31,0.27,0.51,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.37,0.43,0.37,0.52,0.51,0.55,0.37,0.43,0.23,0.31,0.51,0.23,0.44,0.23,0.52,0.37,0.51,0.31,0.43,0.27,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 30. Li, Y., Li, H., Yang, F., Smith-Gill, S. J. &amp; Mariuzza, R. A. X-ray snapshots of the maturation of an antibody response to a protein </text>
   <text y="655.377" x="167.615,170.84,174.8,177.125,179.135,182.585,185.773,189.875,191.585" svgx:width="0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">antigen. </text>
   <text y="655.377" x="193.115,198.185,201.695,203.998,205.543,208.97,211.205,214.017,217.985,220.88,223.182,224.727,228.95,230.967,234.417" svgx:width="0.7,0.49,0.31,0.23,0.47,0.31,0.37,0.53,0.38,0.31,0.23,0.58,0.27,0.47,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nat Struct Biol</text>
   <text y="655.377" x="236.285" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="655.377" x="237.815,241.565" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">10</text>
   <text y="655.377" x="245.315,247.025,248.555,252.155,255.755,259.355,263.255,266.855,270.456,274.056,275.586,278.181,281.781,285.381,288.981,292.581,295.176" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 482–488 (2003).</text>
   <text y="663.875" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,169.961,173.741,177.857,181.089,183.887,185.642,187.329,190.553,192.309,193.996,197.924,199.68,201.435,203.122,208.723,211.999,215.268,217.622,219.377,221.064,224.289,226.044,227.731,233.521,235.276,237.031,238.719,242.588,246.524,250.311,252.597,255.783,257.538,259.226,261.422,263.177,264.932,266.619,272.048,275.28,279.276,283.197,286.43,289.196,292.689,295.922,298.275,300.03,301.718,308.445,310.2,311.888,315.488,317.243,318.93,324.308,325.995,333.037,335.092,339.096,341.382,344.615,346.968,348.723,350.411,355.818,357.573,359.261,364.03,367.263,371.184,373.148,376.485,379.703,381.758,385.845,389.4,391.087,393.463,397.482,400.715,402.402,405.62,409.398,415.443,419.364,421.306,424.539,430.695,433.927,437.931,440.307,443.576,446.447,448.411,450.765,454.252,456.967,460.972,464.205,466.491,469.723,472.594,478.782,480.837,484.984,487.039,491.125,494.68,496.368,499.097,502.329,505.92,507.975,511.754,515.841,518.638,520.326,522.381,526.528,528.216,531.553,533.241,537.147,541.174,547.338,550.607,554.71" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.33,0.51,0.55,0.43,0.37,0.23,0.23,0.56,0.23,0.23,0.62,0.23,0.23,0.23,0.74,0.43,0.44,0.37,0.23,0.23,0.56,0.23,0.23,0.77,0.23,0.23,0.23,0.53,0.51,0.51,0.31,0.43,0.23,0.23,0.33,0.23,0.23,0.23,0.74,0.43,0.53,0.51,0.43,0.37,0.47,0.43,0.37,0.23,0.23,0.89,0.23,0.23,0.47,0.23,0.23,0.71,0.23,0.97,0.27,0.55,0.31,0.43,0.37,0.23,0.23,0.71,0.23,0.23,0.63,0.43,0.52,0.25,0.44,0.42,0.27,0.55,0.47,0.23,0.31,0.53,0.43,0.23,0.42,0.51,0.82,0.52,0.25,0.43,0.82,0.43,0.55,0.31,0.44,0.37,0.27,0.31,0.46,0.36,0.53,0.43,0.31,0.43,0.37,0.82,0.27,0.55,0.27,0.55,0.47,0.23,0.37,0.43,0.47,0.27,0.51,0.55,0.37,0.23,0.27,0.55,0.23,0.44,0.23,0.53,0.53,0.82,0.44,0.55,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 31. Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S. &amp; Winter, G. Replacing the complementarity-determining regions in a human </text>
   <text y="672.372" x="167.608,170.833,174.793,177.118,179.098,182.975,186.867,190.775,194.218,195.748,200.908,202.828,205.16,209.165,210.695,213.028,217.003,220.828,223.641,226.828,228.358,230.653,233.338,237.073,243.215,244.745,248.038,249.568,255.68,259.423,263.382,266.195,269.337,271.047" svgx:width="0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.69,0.27,0.31,0.53,0.23,0.31,0.53,0.51,0.37,0.43,0.23,0.3,0.37,0.51,0.82,0.23,0.44,0.23,0.82,0.51,0.53,0.37,0.43,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">antibody with those from a mouse. </text>
   <text y="672.372" x="272.577,277.647,281.157,283.392,287.292,289.895" svgx:width="0.7,0.49,0.31,0.53,0.37,0.4" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nature</text>
   <text y="672.372" x="292.91" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="672.372" x="294.44,298.19,301.94" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">321</text>
   <text y="672.372" x="305.69,307.4,308.93,312.53,316.13,319.73,323.63,327.23,330.83,334.43,335.96,338.555,342.155,345.755,349.355,352.956,355.551" svgx:width="0.23,0.23,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 522–525 (1986).</text>
   <text y="680.87" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.22,173.335,176.123,179.42,182.747,185.159,186.974,188.864,194.151,195.966,197.781,199.671,204.716,206.831,213.078,214.893,216.783,221.148,222.963,224.853,228.84,230.655,232.545,237.983,239.873,245.277,248.165,251.424,254.421,256.236,258.126,260.381,262.196,264.086,266.341,268.156,270.046,274.873,278.803,281.718,285.01,287.325,289.759,293.157,298.419,302.48,304.907,306.989,310.969,314.964,318.973,322.751,324.566,326.456,329.783,333.845,336.272,338.354,342.333,346.328,350.338,353.885,355.775,359.353,362.68,365.609,367.744,371.078,374.939,376.941,380.234,382.124,384.911,388.203,391.853,393.968,397.806,402.013,403.903,407.981,411.818,418.032,421.907,423.909,427.839,431.631,435.179,437.069,443.283,447.278,451.343,454.602,456.605,458.72,462.864,466.479,468.369,471.284,474.576,477.678,481.193,484.485,486.897,488.712" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.47,0.27,0.37,0.42,0.44,0.37,0.23,0.23,0.69,0.23,0.23,0.23,0.67,0.27,0.82,0.23,0.23,0.57,0.23,0.23,0.62,0.23,0.23,0.71,0.23,0.71,0.37,0.44,0.46,0.23,0.23,0.33,0.23,0.23,0.33,0.23,0.23,0.63,0.51,0.37,0.43,0.31,0.31,0.44,0.69,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.46,0.44,0.37,0.27,0.44,0.51,0.25,0.43,0.23,0.37,0.43,0.47,0.27,0.51,0.55,0.23,0.53,0.51,0.82,0.51,0.25,0.51,0.47,0.46,0.23,0.82,0.51,0.53,0.43,0.25,0.27,0.55,0.47,0.23,0.37,0.43,0.37,0.46,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 32. Sircar, A., Kim, E. T. &amp; Gray, J. J. RosettaAntibody: antibody variable region homology modeling server. </text>
   <text y="680.87" x="490.602,495.738,499.811,502.689,504.632,507.735,509.858,512.826,514.731,519.589,522.558,524.68,528.624,531.254,533.159,537.747,540.79" svgx:width="0.7,0.53,0.38,0.25,0.4,0.27,0.38,0.23,0.66,0.38,0.27,0.51,0.34,0.23,0.6,0.4,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Nucleic Acids Res</text>
   <text y="680.87" x="543.313" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="680.87" x="545.203,549.05" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">37</text>
   <text y="680.87" x="552.898,554.608" svgx:width="0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, </text>
   <text y="689.367" x="167.608,174.891,178.491,182.091,185.691,189.591,193.191,196.791,200.391,201.921,204.516,208.116,211.716,215.316,218.916,221.511" svgx:width="0.97,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">W474–479 (2009).</text>
   <text y="697.865" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.501,174.688,178.565,180.41,183.853,187.183,190.858,194.563,197.488,199.198,200.73,205.913,207.623" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.62,0.43,0.52,0.25,0.46,0.44,0.5,0.51,0.46,0.23,0.23,0.69,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 33. Teplyakov, A. </text>
   <text y="697.865" x="209.158,212.105,214.408,215.953,219.546" svgx:width="0.4,0.31,0.23,0.49,0.25" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">et al</text>
   <text y="697.865" x="221.413,223.123,224.653,229.813,233.773,236.098,238.078,241.955,245.847,249.755,253.197,254.727,260.84,264.732,268.692,271.85,273.747,275.757,279.8,283.31,284.84,288.11,290.825,293.637,296.825,299.54,302.292,308.405,311.592,315.552,317.84,319.37,321.927,324.485,326.195,327.725,331.175,333.5,336.357,340.339,343.564,345.777,349.759,352.444,355.632,358.384,359.914,363.139,367.212,371.172,372.702,378.813,382.706,386.666,389.823,391.698,394.451,396.161" svgx:width="0.23,0.23,0.69,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.82,0.51,0.53,0.43,0.25,0.27,0.55,0.47,0.23,0.44,0.37,0.37,0.43,0.37,0.37,0.82,0.43,0.55,0.31,0.23,0.34,0.34,0.23,0.23,0.47,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.37,0.23,0.44,0.55,0.53,0.23,0.82,0.51,0.53,0.43,0.25,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">. Antibody modeling assessment II. Structures and models. </text>
   <text y="697.865" x="397.691,401.823,404.426,407.861,410.088,413.088,415.038,419.028" svgx:width="0.55,0.37,0.47,0.31,0.4,0.27,0.53,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">Proteins</text>
   <text y="697.865" x="421.556" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="697.865" x="423.103,426.853" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">82</text>
   <text y="697.865" x="430.603,432.313,433.843,437.443,441.043,444.643,448.243,452.143,455.743,459.343,462.943,466.543,468.073,470.668,474.268,477.868,481.468,485.068,487.663" svgx:width="0.23,0.23,0.48,0.48,0.48,0.48,0.52,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 1563–1582 (2014).</text>
   <text y="706.362" x="155.608,155.698,159.298,162.898,164.608,166.333,167.608,171.646,174.852,178.791,181.104,184.374,187.502,190.667,193.397,195.084,196.509,201.297,202.984,204.409,206.542,208.23,209.655,214.965,216.39,222.925,226.131,228.891,232.096,236.157,239.407,242.137,243.825,245.25,250.215,251.902,253.327,258.52,260.208,261.633,268.293,273.453,277.445,280.175,281.862,283.287,286.557,287.982,291.945,295.075,297.388,300.601,304.428,307.679,310.472,313.637,315.062,318.777,320.975,322.4,328.492,332.365,336.216,340.215,342.116,345.321,348.081,349.506,352.712,356.652,358.957,360.917,364.775,368.648,372.536,375.956,377.381,381.328,384.533,387.371,389.637,392.367,393.792,395.924,399.64,402.4,403.825,407.645,410.311,413.516,417.453,419.441,422.645,424.951,426.938,430.961,434.449,435.874,438.097,441.262,444.1,446.405,448.418,451.623,454.603,458.023,459.448,462.144,464.448,467.286,471.246,474.451,476.644,480.604,483.269,486.434,489.164,490.589,493.794,497.847,501.784,503.209,507.147,510.312,513.042,515.029,518.556,522.636,524.624,528.647,532.134,533.559,536.765,542.727,546.807,548.708,550.998,554.441" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.56,0.44,0.55,0.31,0.44,0.42,0.43,0.37,0.23,0.23,0.63,0.23,0.23,0.33,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.44,0.55,0.44,0.37,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,0.89,0.69,0.56,0.37,0.23,0.23,0.44,0.23,0.53,0.44,0.31,0.44,0.51,0.44,0.37,0.43,0.23,0.51,0.3,0.23,0.82,0.51,0.53,0.53,0.25,0.44,0.37,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.52,0.44,0.37,0.31,0.37,0.23,0.3,0.51,0.37,0.23,0.52,0.37,0.43,0.53,0.27,0.42,0.31,0.27,0.55,0.47,0.23,0.31,0.43,0.37,0.31,0.27,0.44,0.37,0.46,0.23,0.37,0.31,0.37,0.53,0.42,0.31,0.53,0.37,0.43,0.37,0.23,0.44,0.55,0.53,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.27,0.55,0.47,0.23,0.44,0.8,0.55,0.27,0.31,0.46,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 34. Pantazes, R. J. &amp; Maranas, C. D. MAPs: a database of modular antibody parts for predicting tertiary structures and designing affinity </text>
   <text y="714.86" x="167.608,173.728,176.878,179.091,183.073,185.758,188.983,192.943,194.473,197.698,201.658,203.983,205.963,209.841,213.733,217.693,219.703,222.891,225.643,227.353" svgx:width="0.82,0.44,0.31,0.53,0.37,0.43,0.53,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.27,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">matured antibodies. </text>
   <text y="714.86" x="228.883,233.226,239.683,244.446,245.991,250.213,252.231,255.681,257.631,261.546,263.504,266.954,269.766,275.616,279.126,281.361,283.379,286.244" svgx:width="0.58,0.88,0.63,0.23,0.58,0.27,0.47,0.27,0.53,0.27,0.47,0.37,0.79,0.49,0.31,0.27,0.38,0.34" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">BMC Bioinformatics</text>
   <text y="714.86" x="288.771" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="714.86" x="290.301,294.051" svgx:width="0.5,0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">14</text>
   <text y="714.86" x="297.801,299.511,301.041,304.641,308.241,311.841,313.371,315.966,319.566,323.166,326.766,330.366,332.961" svgx:width="0.23,0.23,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, 168 (2013).</text>
   <text y="723.357" x="155.601,155.691,159.291,162.891,164.601,166.326,167.601,171.732,173.748,175.51,177.22,181.156,182.919,184.681,186.391,190.5,193.776,197.787,200.17,203.515,206.718,209.958,212.763,214.525,216.235,221.094,222.856,224.566,226.77,228.532,230.242,235.627,237.337,243.943,247.219,250.054,253.33,257.461,260.782,263.587,265.35,267.06,272.1,273.862,275.572,280.836,282.598,284.308,289.999,293.898,296.238,302.973,307.479,312.804,317.116,321.271,325.224,328.569,330.279,334.402,337.701,342.891,344.601,346.946,349.781,353.057,359.22,362.519,367.647,371.433,374.237,378.032,379.742,381.945,385.731,388.566,390.276,392.66,396.686,399.926,401.636,405.648,408.888,410.598,414.722,418.478,421.941,425.819,427.529,431.541,434.781,437.586,439.649,443.247,447.402,449.112,452.898,455.171,456.881,460.157,464.168,466.544,468.575,472.503,476.446,480.405,483.9,485.61,489.135,492.411,495.288,497.372,500.655,504.464,506.414,509.654,511.364,514.1,517.34,520.938,523.0,526.786,530.941,532.651,538.815,542.757,546.77,549.978,551.904,554.657" svgx:width="0.23,0.48,0.48,0.23,0.23,0.55,0.54,0.27,0.23,0.23,0.62,0.23,0.23,0.23,0.56,0.44,0.55,0.31,0.44,0.42,0.43,0.37,0.23,0.23,0.63,0.23,0.23,0.33,0.23,0.23,0.71,0.23,0.89,0.44,0.37,0.44,0.55,0.44,0.37,0.23,0.23,0.67,0.23,0.23,0.74,0.23,0.23,0.75,0.52,0.31,0.89,0.69,0.7,0.57,0.55,0.52,0.44,0.23,0.55,0.43,0.69,0.23,0.3,0.37,0.44,0.82,0.43,0.69,0.51,0.37,0.5,0.23,0.3,0.51,0.37,0.23,0.31,0.53,0.43,0.23,0.53,0.43,0.23,0.55,0.51,0.46,0.51,0.23,0.53,0.43,0.37,0.27,0.47,0.55,0.23,0.51,0.3,0.23,0.44,0.55,0.31,0.27,0.51,0.51,0.53,0.46,0.23,0.46,0.44,0.37,0.27,0.44,0.51,0.25,0.43,0.23,0.37,0.43,0.47,0.27,0.51,0.55,0.23,0.82,0.51,0.53,0.43,0.25,0.37,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> 35. Li, T., Pantazes, R. J. &amp; Maranas, C. D. OptMAVEn–a new framework for the de novo design of antibody variable region models </text>
   <text y="731.855" x="167.601,169.933,173.158,175.881,179.331,182.518,184.842,186.852,190.895,194.405,195.935,198.65,202.647,205.872,209.045,211.055,215.067,218.24,219.77,222.995,226.955,229.28,231.29,234.74,237.927,242.03,243.56,246.747,250.587,252.507,254.75,258.492,262.49,265.677,268.43,270.14" svgx:width="0.31,0.44,0.37,0.47,0.43,0.31,0.27,0.55,0.47,0.23,0.37,0.52,0.43,0.42,0.27,0.54,0.42,0.23,0.44,0.55,0.31,0.27,0.47,0.43,0.55,0.23,0.43,0.52,0.27,0.31,0.51,0.52,0.43,0.37,0.23,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">targeting specific antigen epitopes. </text>
   <text y="731.855" x="271.67,275.727,279.74,283.265,286.775,288.32,293.66,297.597" svgx:width="0.55,0.53,0.47,0.47,0.23,0.71,0.53,0.4" style="fill:rgb(0,0,0);font-family:MinionPro-It;font-size:7.5px;stroke:none;">PLoS One</text>
   <text y="731.855" x="300.597" svgx:width="0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;"> </text>
   <text y="731.855" x="302.136" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:MinionPro-Bold;font-size:7.5px;stroke:none;">9</text>
   <text y="731.855" x="305.886,307.596,309.126,312.313,315.913,319.513,323.113,326.713,330.313,333.913,335.443,338.038,341.638,345.238,348.838,352.438,355.033" svgx:width="0.23,0.23,0.43,0.48,0.48,0.48,0.48,0.48,0.48,0.23,0.35,0.48,0.48,0.48,0.48,0.35,0.23" style="fill:rgb(0,0,0);font-family:MinionPro-Regular;font-size:7.5px;stroke:none;">, e105954 (2014).</text>
  </g>
 </g>
</svg>
